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Abstract 
Objective:  
To evaluate the recruitment, follow up and morbidity patterns of infants enrolled in the 
tuberculosis (TB) epidemiological cohort study in Siaya County, western Kenya in 
preparation for future TB pediatric trials. 
Methods: 
An observational prospective TB cohort study that enrolled 2900 infants.  Infants were 
recruited through birth notifications and screened for eligibility. Mothers were consented prior 
to infants’ enrollment into the study. Upon enrollment, mothers were asked for antenatal 
profiles, demographic and baseline information. Follow-up visits were 1-2 years at six weeks 
and thereafter four-monthly. Mothers whose enrolled infants fell sick were reimbursed 
transport when they came to study clinic. Univariate analyses on infant and maternal 
characteristics. Bivariate and logistic regression models were performed to identify factors 
associated with place of delivery, loss to follow up (LTFU) and unscheduled visits. Kaplan 
Meier curves and Cox Proportional Hazards were used to explore LTFU factors.  
 
Results: 
Village reporters contributed 98% of the birth notifications, 98% of infants were enrolled 
from home, 63% of infants were home delivered, 82% of mothers had primary education and 
14% of mothers were HIV positive. BCG coverage was improved from 25% to 87% post 
enrollment. Cohort retention was 91.5%.  
 
No or lower maternal education, farming mothers, salaried mothers, mothers engaged in 
fishing, mothers living in mud houses, mothers living in semi-permanent housing and receipt 
of antenatal care was associated with home delivery. 
 
Home delivered infants, infant birth weight, mothers engaged in farming, mothers employed 
as salaried workers, mother living in mud type of housing and mothers with ≥ γ children were 
associated with loss to follow up (LTFU). 
  
Infant delivered at home, infants residing within the HDSS area, no maternal or primary 
education, HIV positive mothers, and maternal age were associated with unscheduled visits. 
 
Inpatient symptoms were fevers, fast breathing and vomiting whereas outpatient symptoms 
were breathing difficulty, fevers and fast breathing. Malaria and upper respiratory tract 
infections were the leading impressions. Common prescriptions dispensed were antimalarials, 
analgesics and antihistamines. Unscheduled visits identified TB suspects and TB cases that 
would have been missed. 
 
Conclusion: 
Infant cohort retention was impressive. Study withdrawals and choice of place of delivery 
require further qualitative assessment. Consideration of factors associated with LTFU and 
unscheduled visits to inform the planning and implementation of future pediatric studies.  
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1. Introduction 
 
Tuberculosis (TB) remains a major global health problem, responsible for ill health among 
millions of people each year. TB ranks as the second leading cause of death from an 
infectious disease worldwide after human immunodeficiency virus (HIV). There are 22 TB 
high burden countries that altogether contribute about 80% of the global TB burden. The 
greatest burden of TB is in sub-Saharan Africa and South East Asia regions (WHO, 2014). 
 
Source: World Health Organization TB Report, 2014 
Kenya is ranked 15th among the 22 TB high burden countries that collectively contribute to 
about 80% of the world TB cases and also ranks 5
th
 in Sub Saharan Africa (WHO, 2011). 
Various factors have been identified as risk factors for TB disease (Lonnroth et al., 2009) but 
in Kenya majorly attributed to the HIV pandemic (Chintu et al., 2002, Gilks et al., 1997). 
Historically, paediatric tuberculosis has been neglected largely due to the challenges 
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associated with uncertainty in diagnosis and low priority accorded by national TB control 
programs (Marais and Pai, 2007). TB disease in a child is considered a sentinel event because 
it usually represents disease resulting from recent transmission from an adult with infectious 
pulmonary TB (Myers et al., 2006, Swaminathan and Rekha, 2010). One of the main hurdles 
hampering efforts to control TB globally is the ability to identify and diagnose cases 
especially poor among children (Trunz et al., 2006). The epidemiology of TB in young 
children (<5 years old), a vulnerable population where diagnosis and treatment are most 
challenging, is not well understood, especially in countries with limited public health 
resources (Jain et al., 2013). In addition, pediatric TB is complicated by the unique challenges 
that it poses to TB control (Cardy et al., 2012). Children generally make up only a small 
proportion of TB cases, but in some high-incidence countries up to 15% of all TB cases occur 
in children (Nicholson et al., 2011). The fact that children rapidly progress to active disease 
and represent a potential pool for disease in their adult life, further underlines the importance 
of analysing the epidemiology of childhood TB (Sandgren et al., 2011). The risk of 
developing disease has been estimated to be 24% in children 1–5 years of age, and 
unfortunately as high as 43-50% in infants less than a year of age (Hesseling et al., 2009). The 
youngest children carry the biggest burden for three main reasons: firstly, they are more prone 
to develop severe extrapulmonary TB disease such as meningitis and miliary TB; secondly, 
they tend to develop severe pulmonary disease with bronchial obstruction; and thirdly, they 
are more likely to develop disease after being infected (Weber et al., 2000). Bacille Calmette 
Guerin (BCG) vaccine given at birth has benefits that clearly outweigh its risks in most 
settings and populations (Abu-Raddad et al., 2009), there is an urgent need for a more 
effective and safer TB vaccine for children (Rowland and McShane, 2011). However, studies 
on the epidemiology, clinical profile, and treatment outcomes of childhood TB from 
developing countries are lacking (Edmond et al., 2006, Anderson et al., 2014, Newton et al., 
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2008). The significant TB-related morbidity and mortality suffered by children in high-burden 
settings (Trunz et al., 2006), underlines the need to obtain a more comprehensive picture of 
childhood TB at the community level in high-burden settings. Childhood TB nevertheless 
remains neglected, as the perception in resource limited settings rule out children as not a 
public health risk (Marais et al., 2006, Hesseling et al., 2009, Swaminathan and Rekha, 2010). 
1.1. Recruitment of infants into studies 
 
Observational studies in children with TB are often hospital-based, which may result in 
considerable bias, preventing accurate extrapolation to the community level (Marais and Pai, 
2007). Multicentric pediatric trials are urgently required to help develop improved diagnostic 
strategies and formulate shorter, more effective, safe, and evidence-based regimens for 
treatment and prevention of drug susceptible and drug-resistant TB (Swaminathan and Rekha, 
2010). Although reporting of the recruitment and retention of participants in randomised trials 
has improved with the advent of the CONSORT Statement (Altman et al., 2001, Moher et al., 
1994, Schulz et al., 2010), detailed protocols and the lessons learnt are rarely described 
(Toerien et al., 2009). A review of 114 trials reported that only 38 (31%) achieved their 
original recruitment target (McDonald et al., 2006). When consent rates are low and 
additionally loss to follow up and withdrawals may result in high attrition, the potential for 
selection bias and retention bias is increased. Both biases limit the generalisability of results, 
and reduce the successful translation of any positive outcome effects into practice (Fewtrell et 
al., 2008). In a study, where interviewed parents about their decision for or against enrolling 
their child in a vaccine study, the data analysis suggests that parents’ ability to evaluate a 
vaccine study depended on how attuned they are with science and medicine, either 
professionally or as consumers of health services. Familiarity does not predispose parents to 
enrolling their child in research; rather, it is a predictor of parents’ confidence in their 
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decision making (Chantler et al., 2007). Neonatal research is made more complex by the issue 
of proxy consent. Obtaining valid informed consent for entry of an infant into a research 
project needs to deal with this complexity. New evidence on the role and responsibilities of 
parents in giving consent has implications for all clinical staff that are considering embarking 
on and/or recruiting infants in research projects (McKechnie and Gill, 2006). A cross 
sectional survey to quantify refusal rates and factors of refusing pertaining to studies and 
recruiting pediatricians showed that refusal to participate in clinical research was low and 
influenced by factors associated to the objectives, conduct of the studies and factors related to 
the characteristics and perceptions of the recruiting pediatricians (Kaguelidou et al., 2013). 
 
For many pediatric studies, the relative scarcity of potential study participants means that it 
often takes considerable effort that requires lots of creativity to enroll and retain sufficient 
numbers of children who meet the criteria for study participation. It may also mean that 
studies must extend for quite long periods just to secure enough participants. One recently 
published article on the prevention of fungal infections in children and adults with chronic 
granulomatous disease reported that it took 10 years to enroll 39 participants, most of whom 
were children at the time that the study started (Gallin et al., 2003). A review of randomized 
controlled trials published in the Archives of Diseases in Childhood from 1982 to 1996 
reported that about half of the studies recruited less than 40 children, with medians of 80 
children for multicenter trials and 36 children for single-center studies (Campbell et al., 1998, 
Pattishall, 1990, Freiman et al., 1978, Moher et al., 1994). The authors comment that these 
small studies “have inadequate power to detect small or moderate treatment effects and result 
in a significant chance of reporting false-negative results”(Campbell et al., 1998). In recent 
years, various initiatives have aimed at furthering paediatric research, as the absence of 
adequate studies in the paediatric population has hampered progress in the care of children 
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(Burns, 2003, Koren et al., 2003). A key determinant of the success of a clinical trial is the 
recruitment and retention of a study population of an adequate sample size. Low rates of 
recruitment and retention have a number of negative implications, such as longer durations of 
the clinical trial, which may lower staff and participant morale; a costlier clinical trial, since 
extra resources may need to be dedicated to the recruitment effort; and less statistical power 
for both the study and the validity of the results would be in doubt. In some cases, inadequate 
accrual of subjects may result in the termination of the trial (Ross et al., 1999, Hunninghake et 
al., 1987, Lovato et al., 1997). Poor clinical trial recruitment and retention is therefore likely 
to impede the successful evaluation of new and existing interventions, and prevent greater 
efficiency in clinical development (Spilker and Cramer, 1992). There is scarce data about 
recruitment and retention in TB cohort studies especially among infants. Researchers, 
healthcare providers, and parents acknowledge the importance of research, but effective 
recruitment into paediatric clinical trials remains a difficult task (Caldwell et al., 2002, 
Singhal et al., 2004, McKechnie and Gill, 2006). Recruiting infants into clinical studies can be 
challenging and there is need for researchers to acrrue target participants in an effective and 
timely fashion in order to represent valid results. Several studies have examined their 
recruitment experience in various ways (Kaur et al., 2012, Vollmer et al., 1992, Heinrichs et 
al., 2005, Bailey et al., 2004, Strunk R, 1999). There are reports from trialists reporting their 
recruitment experience, methods and strategies (Finne et al., 2009). Little has been 
documented about recruitment and strategies employed to complete studies in time (Galbreath 
et al., 2008). In a proof of concept study to assess the novel T-cell activation marker–
tuberculosis assay for diagnosis of active tuberculosis in children, children aged older than 6 
months and younger than 16 months were referred from peripheral health facilities and local 
hospitals (Portevin et al., 2014). In yet another study conducted in Africa to diagnose 
childhood tuberculosis and host RNA expressions were recruited from children admitted and 
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undergoing TB evaluation in the hospital (Anderson et al., 2014). In neighbouring Uganda, a 
site under Makerere University Demographic Surveillance System, recruited and enrolled 
infants ≤ 8 weeks either at health facilities or at home through village scouts (Nabongo et al., 
2014). 
1.2. Place of Delivery 
 
Mothers in developing countries still prefer home delivery unattended by skilled health 
workers to health facility delivery (Montagu et al., 2011). In several contexts, individual 
factors including maternal age, parity, education and marital status, household factors 
including family size, household wealth, and community factors including socioeconomic 
status, community health infrastructure, region, rural/urban residence, available health 
facilities, and distance to health facilities determine place of delivery (Stephenson et al., 
2006). A study looked at antenatal care and delivery care among women in western Kenya 
and demonstrated that older women, high parity, lower socioeconomic status, low education 
levels and more than an hour walking distance were associated with delivery outside health 
facilities (van Eijk et al., 2006). Health or home delivery was significant in determining the 
subsequent steps by study such as administration of BCG vaccination, whether to enroll at the 
home or health facility. Understand the differences between home and health facility enrolled 
infants in terms of follow-up and unscheduled visits attendance using baseline variables from 
infants and mothers. One challenging task for the tuberculosis cohort study was to 
demonstrate the ability to demonstrate the capacity to recruit and enroll 2900 participants in a 
rural setting.  
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1.3. Loss to Follow Up in Pediatric Studies 
 
Loss to follow up (LTFU) can be problematic and lead to bias (Kristman et al., 2004). A 
multicenter cohort study in Europe of children aged 2-9 years old found that being 
overweight, low education, single parenthood and low-well being were determinants of 
attrition (Hense et al., 2013). In the Avon Longitudinal Study of Parents and Children, an 
association was established between socio-economic position and study outcomes (Howe et 
al., 2013). In a large HIV-1 perinatal transmission cohort study in Malawi established infants 
with low birth weight and singletons were less likely to return for follow-up. Parents from 
farming background, educated and students were also less likely to be loss to follow-up 
(Ioannidis et al., 1999). In an isoniazid prophylaxis study with 2 cohorts, HIV infected and 
HIV exposed and not infected, a larger household and presence of an elder was associated 
with decreased LTFU. Among HIV negative, younger maternal age increased risk for loss to 
follow up whereas maternal history of TB reduced the risk of LTFU (Beneri et al., 2013). In a 
study of Fetal Malnutrition in Nigeria, attrition at 4 weeks follow-up was higher among 
mothers who had no antenatal care, teenage mothers, primiparous mothers, low social class, 
mothers of female children, among clinically well babies and mothers of babies without fetal 
nutrition (Olusegun et al., 2007). In a study to describe attrition comprehensively in an asthma 
intervention study, they found out that caregiver age predicted dropout (Zebracki et al., 2003). 
In a 5 year follow up of mother and child pairs in prevention of mother to child transmission 
of HIV (PMTCT) study, HIV negative mothers were LTFU (Kurewa et al., 2012). In the 
“Making Our Mealtimes Special” (MOMS) study targeting low income populations knew that 
successful recruitment and retention of low-income and/or minority participants present a 
unique set of challenges (Nicholson et al., 2011). In the HIV Prevention Trials Network 
(HPTN) 064 study, factors associated with missed study visits were unstable housing and later 
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enrollment whereas black race, recruitment from an outdoor venue and financial 
responsibility for children increased likelihood of attendance of study visits (Haley et al., 
2014). Older maternal age was associated with better study participation in a large clinical 
trial to reduce prevention of mother to child transmission of HIV (PMTCT)(Sellers et al., 
2014). In the Avon Longitudinal Study of Parents and Children, loss to follow-up was 
associated with socio-economic position (SEP) and outcomes such as birth weight and length, 
breastfeeding, preterm birth, maternal obesity, smoking during pregnancy, educational 
attainment (Howe et al., 2013).  
1.4. Morbidity patterns among infants 
 
Influenza is major cause of pediatric hospitalisation but recruiting sufficient controls was 
problematic and in the future (Dixon et al., 2010). Recruiting for research studies is always a 
challenge, particularly in paediatric studies. In this study, experiences recruiting children to 
five studies through primary care demonstrated evidence that participants who had 
participated in previous studies were more likely to participate again (Cardy et al., 2012).  In 
sub-Saharan Africa (SSA), fever remains a major public health problem. Fever is a symptom 
of diseases especially predominant among children under age five (Nnedu et al., 2010). Such 
diseases include malaria, diarrhoea, pneumonia, measles, polio and tuberculosis, to mention a 
few. These diseases are main contributors to deaths among children under age five in the sub-
Saharan African region (Black et al., 2003). The World Health Organization’s (WHO) 1999 
report on infectious diseases posits that these diseases cause most of the deaths from 
infectious diseases. Respiratory diseases are a leading cause of hospital admissions in both 
HIV-1-positive and HIV-1-negative children worldwide (Chintu et al., 2002). Previous 
research has shown that various factors influence child health and survival, including place of 
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residence, breastfeeding, place of delivery, access to postnatal care, and maternal age and 
education (Doctor, 2001, Swenson et al., 1993, Teka et al., 1996, Edmond et al., 2006, Black 
et al., 2003, Manda, 1999, Nath et al., 1994). Observational studies have reported 
substancially increased diarrhea in artifically fed infants, with highest risk being noted in the 
first 2 to 3 months of life (Jason et al., 1984, Feachem and Koblinsky, 1984). In a study that 
looked at diarrhea among children with known HIV status, it was found that diarrhea was 
frequent among HIV positive children (van Eijk et al., 2006). Low birth weight is a risk factor 
for infant mortality. WHO 1998 report states that “fetal anaemia is also an important risk 
factor for anaemia in the first six months of life” and may contribute to mortality risk 
(Wilcox, 2001). “As low birth weight and fetal anaemia have been related to malaria in 
pregnancy” (McCormick, 1985, le Cessie et al., 2002, Verhoeff et al., 1999, Brabin, 1992). It 
is important to establish their association with infant morbidity in malaria endemic areas. In a 
health seeking behavior, mothers classified childhood illnesses into four categories: not 
serious – coughs, colds, diarrhea; serious but not life threatening – malaria; sudden and 
serious – pneumonia; chronic and therefore not requiring immediate action – malnutrition, 
tuberculosis, chronic coughs (Amuyunzu-Nyamongo and Nyamongo, 2006). 
 
The different determinants of infant morbidity and mortality include age, sex, plurality, mode 
of delivery, gestational age, infant birth weight, parity of mother, vaccination, maternal 
education, age, birth spacing and socioeconomic conditions. Breast feeding is an important 
determinant which lowers the rate of infection related morbidities (Kramer et al., 2001). 
WHO Expanded Programme on Immunization has reduced infant mortality by controlling 
vaccine preventable diseases (Kabir et al., 2003). There are only a few reports of morbidity 
associated with underweight at childhood and adolescence in industrialized societies (Booth, 
1991, Kraemer et al., 1978).  
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The articles reviewed mainly assessed children who made return visits to the hospital 
emergency unit (Alessandrini et al., 2004, Goldman et al., 2006, Imsuwan, 2011, English et 
al., 2003).  Previous studies reviewed majorly addressed, unscheduled return visits at 
emergency departments in hospitals with the view to minimize these visits (Singer et al., 
2014, Cohen et al., 2014) whereas others targeted adult populations (van der Linden et al., 
2014, O'Connor et al., 2014, Akenroye et al., 2014). Infant where not breastfed were 
associated with increased risk of serious infections between 0-2.9 months of age in a HIV-
exposed, uninfected infants in the first 6 months of life (Bork et al., 2014). A study comparing 
the frequencyof hospitalizations between breastfed, partially breast-fed and bottle-fed infants 
showed that breastfed infants had fewer admissions (Shiva et al., 2007). Upper respiratory 
tract infections (URTIs) was identified as one of the leading extreme events especially among 
prematurely born infants (Al-Kindy et al., 2009). Leading infections in a prospective follow-
up of children attending municipal day centers in Helsinki found that URTI was one of the 
most diagnosed infection (Ponka et al., 1991). Younger age and day care outside home were 
identified as contributors to infectious morbidity. There was no difference in symptom days 
between children with or without older siblings (Hedin et al., 2010). Incidences of morbidities 
were more among partially immunized babies and among mothers with lower socio-
economical and educational status (Joseph et al., 2013). Morbidity was more among boys and 
in the second half of infancy. Respiratory tract infections, diarrhea and skin infections were 
the commonest morbidities (Joseph et al., 2010). Infants with lower tract infections were 
hospitalized more frequently (Mussi-Pinhata et al., 2007). Diarrhea and malaria were most 
common between 6-12 months of age and especially during rainy season whereas acute 
respitatory illness reportedly frequent between 1-3 months of age and in the cold season 
(Vaahtera et al., 2000). In a study in Nairobi slum settlements, morbidity was influenced by 
child age, ethnicity and type of toilet whereas health seeking behavior was linked to child's 
22 
 
age, type and severity of illness, survival of father and mother, mother's education, mother's 
work status and wealth class (Ndugwa and Zulu, 2008). Respiratory disease is the major cause 
of mortality and morbidity worldwide, with infants and young children especially susceptible 
(Zar and Ferkol, 2014). Tuberculosis is a large source of morbidity and mortality among 
children. However, limited studies characterize childhood tuberculosis disease, and contact 
investigation is rarely implemented in high-burden settings (Jaganath et al., 2013). There is 
very little reported literature on post-birth newborn morbidity and therefore a secondary 
analysis of data from a randomized clinical trial assessed infants' health in the first eight 
weeks and established that the most common infant morbidity was upper respiratory illness 
(Hannan, 2014).  
1.5. Categorization of cited studies due to key criterions 
 
Literature review was conducted and there are studies that were carried out and identified to 
be linked to the thesis criterions as follows: 
 
Table 1. Categorization of cited studies according to thesis criterions 
Outcome Country Sample size Study Type Year of 
Completion 
Author(s) 
Recruitment of 
infants into 
studies 
Uganda 2500 Observational 
cohort 
2010 Nabongo et. 
al., 2014 
South Africa, 
Malawi and 
Kenya 
2955 Prospective 
tuberculosis 
study 
2011 Anderson et. 
al., 2014 
Tanzania 290 Proof-of-
concept study 
2012 Portevin et. 
al., 2014 
United States 
of America 
39 Prospective 
study 
2001 Gallin et. al., 
2003 
Place of 
Delivery 
Demographic 
Health Survey 
(DHS) data 
 Secondary 
analysis 
2003 – 2008 Montagu et. 
al., 2011 
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from 48 
countries  
Demographic 
Health Survey 
(DHS) data 
from 6 
countries 
 Secondary 
Analysis 
1999 – 2000 Stephenson et. 
al., 2006 
Kenya 730 Survey 2002 van Eijk et. 
al., 2006 
Loss to Follow 
Up in 
Pediatric 
Studies 
8 countries  in 
Europe 
31543 Population 
based 
intervention 
study 
2010 Hense et. al., 
2013 
United 
Kingdom 
12000 Longitudinal 
study 
Ongoing Howe et. al., 
2013 
Malawi 2156 Prospective 
cohort 
1994 Ioannidis et. 
al., 1999 
South Africa 1351 Secondary 
analysis 
2006 Beneri et. al., 
2013 
Nigeria 473 Prospective 
study 
2002 Olusegun et. 
al., 2007 
United States 
of America 
327 Randomized 
control trial 
2001 Zebracki et. 
al., 2003 
Zimbabwe 1050 Prospective 
cohort study 
2010 Kurewa et. al., 
2002 
Morbidity 
patterns 
among infants 
Australia 76 Case control 
study 
2008 Dixon et. al., 
2010 
 Sierra Leone 175 Prospective 
study 
2005 Nnedu et. al., 
2010 
 Zambia 264 Descriptive 
study 
 Chintu et. al., 
2002 
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2. Rationale and Objectives 
2.1. Rationale 
 
About 1.5 million new tuberculosis (TB) cases occur per year in Sub-Saharan Africa, where 
the prevalence of the disease continues to rise by 3-4% annually and where HIV has been the 
single most important factor determining the increased incidence of TB in the past 10 years. 
The age-specific incidence of TB in developing countries is characteristically high before 5 
years, peaks in the second year, is low between 5 and 12 years of age and then gradually rises 
through adolescence to peak in young adults. BCG given at birth is thought to confer only 
incomplete and variable protection against pulmonary TB. There are also significant safety 
concerns when BCG is used in HIV-infected and other immune-suppressed infants. This has 
prompted the search for new, safer and more efficacious TB vaccines. Several of these 
vaccines are being tested in Phase I and IIA clinical trials, two are planned to start Phase IIB 
proof of concept clinical trials in 2008 and one or more will likely be ready for efficacy 
testing in a Phase III trial within the next 3-5 years. In order to conduct Phase III efficacy 
trials of new TB vaccines, trial sites are needed which have the capacity to enroll and 
vaccinate large numbers of infants, retain them during follow up, and be capable of detecting 
all incident cases of TB and safety endpoints. For example, the ability to vaccinate infants 
within a specified period after birth in an area where the majority of deliveries occur at home 
would be required in a Phase III TB vaccine trial.  
 
In addition, until a validated surrogate marker of protection following vaccination, such as an 
immunologic assay, is available, clinically diagnosed TB is likely to be the endpoint for 
comparison of efficacy of a new vaccine with a control. Planning trials will require 
knowledge of the baseline incidence of TB in the population under study. This will be crucial 
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for determining the sample sizes which will be needed to detect a statistically significant 
reduction in TB incidence in trial populations receiving new TB vaccine candidates. The 
proposed epidemiological cohort study will provide important information needed for the 
accurate planning of future TB vaccine efficacy trials e.g. rates of TB infection and disease in 
the target population. In addition it will help to develop capacity at the site to recruit, 
vaccinate and follow- up a large cohort of infants in such a way as to ensure that all endpoints 
are detected in a timely fashion, properly verified and properly documented. The formative 
qualitative research in the proposed study will provide insights for tailoring efforts to optimize 
recruitment, retention and acceptability; in a future TB vaccine trial and strategies for 
enhancing care seeking during acute illness episodes. A Phase IV BCG trial conducted in 
South African infants showed a cumulative incidence of definite, probable or possible TB of 
6.31% over 2 years. Given this high incidence, infants are a promising target group for future 
large TB vaccine efficacy trials, because they are at high risk for TB and would stand to 
benefit the most from the new technology. Pediatric TB is often under-diagnosed and poorly 
managed due to challenges in case detection and limited pediatric drug formulations.  The -
under-utilization of children in clinical research has led to this dearth of tools for pediatric TB 
prevention, diagnosis, and treatment. 
 
In TB research, efforts are geared towards urgently finding the replacement for Bacille 
Calmette Guerin (BCG) vaccine more than 100 years old. Finding research sites in developing 
countries that are ready for the conduct of phase 3 clinical trials is a daunting task. 
Additionally, pediatric research studies are a novel field in developing countries and 
unexplored. Recruitment of newly born infants into research in Africa can be a challenge as 
few deliveries take place in the hospitals. Loss to follow up reduces the sample size thereby 
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compromising the statistical power of the study. Monitoring sick visits in pediatric 
populations is useful in mitigating severe outcomes and minimizing deaths. European and 
Developing countries Clinical Trials Partnerships (EDCTP) partnered with Kenya Medical 
Research Institute (KEMRI) and Centers for Disease Control and Prevention (CDC) to 
develop capacity of KEMRI/CDC site in western Kenya for late phase TB clinical trials by 
funding a TB epidemiological study among infants to document annual TB incidence. 
2.2. Primary objective: 
 
To evaluate the recruitment, follow-up and morbidity among infants enrolled in a tuberculosis 
epidemiological cohort study in western Kenya for future TB vaccine trials. 
2.3. Specific objectives: 
 
1. To assess the recruitment outcomes, accrual trends and baseline characteristics of 
infants enrolled into TB cohort study 
2. To determine the factors associated with place of delivery among mothers of infants in 
this TB cohort study 
3. To evaluate the predictors of loss to follow up in an infant TB cohort study 
4. To highlight factors influenced by attendance of unscheduled visits in the infant cohort 
study 
5. To describe the morbidity burden among infants enrolled utilizing unscheduled visits 
in an infant TB cohort study 
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3. Methods 
3.1. Study area 
 
KEMRI and CDC collaboration is based in East Africa, Kenya in the third largest lake side 
city called Kisumu at 1,131 meters (3,711 feet). Kisumu is situated in the western part of 
Kenya in the former Nyanza Province. KEMRI/CDC runs a health and demographic 
surveillance system (HDSS) about 70 kilometers from Kisumu in Siaya County at 1,224 
meters (4,019 feet). The HDSS covers Gem, Asembo and Karemo areas that are typically 
rural populations (Figure 2). Western Kenya experiences long rains from March to June and 
short rains from October to December.  
 
Source: KEMRI/CDC Health and Demographic Surveillance System, 2010 
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3.2. Study site 
The study was conducted in Karemo division and contiguous areas e.g Boro, Gem etc, Siaya 
District where the Siaya County Referral Hospital (SCRH) is located. All diagnostic 
procedures were conducted in a case verification ward (CVW) at SCRH. An outpatient annex 
was built at SCRH with laboratory capacity to do basic hematological, chemical, serological, 
and microbiological (excluding all TB) tests for this study. Kenya Medical Research Institute 
(KEMRI) and Centres for Disease Prevention and Control (CDC) already operates a health 
and demographic surveillance system (HDSS) in Gem and Karemo (in Siaya District) and 
Asembo (in Bondo District), which provides general demographic and health information as 
well as disease- or intervention-specific information. KEMRI and CDC operates a health and 
surveillance within out-patient and in-patient public health facilities serving residents of 
Karemo which records symptoms, diagnosis, and treatment information for all children <10 
years of age. KEMRI and CDC initiated a TB prevalence survey in Asembo and Gem in 
August 2006 with a fluorescent microscopy (FM) TB smear laboratory based at KEMRI 
Center for Global Health Research (CGHR) research station in Kisian. The TB laboratory was 
upgraded to a biosafety level 3 (BSL-3) laboratory and create TB culture capacity. 
3.3. HDSS Platform 
 
KEMRI and CDC ran a Health and Demographic Surveillance System (HDSS) is situated in 
Kisumu, Kenya within East Africa, which is a longitudinal, population-based health and vital 
event registration system that monitors demographic (e.g., births, deaths, pregnancies, and 
migrations) and health (e.g., clinic attendance and hospital admission) events in a 
geographically defined population with timely production of data. This continuous 
surveillance makes it possible to easily and clearly define risks of demographic and health 
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events for individuals over time. The HDSS can provide cause-specific mortality and 
morbidity profile that is demographically or geographically stratified, permitting rational 
resource allocation to priority diseases in defined target groups. Accurate sampling frames can 
be generated from HDSS data at multiple levels (individual, house, village) and by several 
strata (age, sex, geographic location) to permit unbiased, population-based sampling. The 
longitudinal morbidity, mortality, and fertility data generated from the HDSS can help 
generate hypotheses on the causes of disease and death in the population and evaluate the 
impact of public health interventions. Finally, significant efficiencies may be achieved when 
multiple research program evaluation activities operate from the same infrastructure and 
population base.  
3.4. Study Population 
The study population were infants born to women who are residents of Karemo division  and 
contiguous areas e.g Boro, Gem, etc. in Siaya District, Nyanza Province, in western Kenya. 
The total population in Karemo division is approximately 73,000 and the annual birth cohort 
3600, of which 80% take place at home. More than 95% of the population is of Luo ethnicity, 
with subsistence farming as the main source of income. Families live in compounds; each 
compound has been mapped using Geographic Information System (GIS) coordinates and 
each individual has been given a unique identification number as part of the HDSS. 
3.5. Study Design 
 
A prospective, observational cohort study that targeted infants aged 0-6 weeks old and born to 
women who resided within the study area was conducted.  Infants were recruited through 
birth notifications followed by prescreening and screening for eligibility. Mothers gave assent  
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prior to enrollment of their  children into the study. Upon enrollment, antenatal profile, 
demographic and baseline information was collected from mothers and infants. Follow up was 
scheduled at six weeks upon enrollment and thereafter four-monthly between 1-2 years 
depending on time of enrollment. Mothers were allowed to make unscheduled visits to the 
clinic at any time they found it necessary for the wellbeing of the infant.  
Loss to follow was defined as follows: three or more documented attempts to contact the 
participant without success; participant confirmed to have moved from study area and not 
traceable; no contact established by the time the study was completed such that there was 
insufficient information to determine the participant’s status irrespective of enrollment period. 
Unscheduled visits were defined as those visits outside the study visits (scheduled visits) 
where mothers brought in their infants to be treated for various illnesses. During these visits, 
the infants were examined for signs and symptoms related to TB or not and investigations 
were requested by study clinicians as deemed necessary. 
3.6. Materials and methods 
 
Study site was situated at Siaya County Referral Hospital. The BCG vaccination administered 
to infants was sourced from Ministry of Health. Electronic case report forms were completed 
on personal digital assistants (PDAs) or hand held computers and laptops on a customized 
data entry interface. Source documentation was also maintained for study participants to allow 
for source data verification with entries in the electronic case forms. The data was saved onto 
an SQL database and exported into STATA 12.0 for statistical analyses. 
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3.7. Study Procedures 
3.7.1. Participant selection criteria 
3.7.1.1. Inclusion Criteria:  
Enrolled infants must have met all of the following criteria: Infant was born within the 
Karemo Division and contiguous areas e.g Boro, Gem etc ; Infant was vaccinated with BCG 
within six weeks of birth ; Infant weighs 1700g or more at the time of vaccination ; Infants 
born to mothers diagnosed with TB will not be excluded from the study but have delayed 
BCG vaccination after INH prophylaxis. 
3.7.1.2. Exclusion Criteria:  
Enrolled infants must have had none of the following: In the opinion of the attending clinician, 
participation in the study may adversely affect the health of the infant (includes infants with 
advanced HIV disease); Parent/guardian declines to give informed consent; Parent/guardian 
plans to move from the study area within the next year. 
3.7.2. Recruitment strategy and process 
 
HDSS households are visited every four months in order that general demographic and health 
information, including reports of pregnancies, may be collected. This system of reporting 
pregnancies was adopted and utilized for study recruitment. Furthermore, village reporters 
(VRs) were utilized as an extra surveillance system outside of the regular HDSS visits to 
identify pregnant women in their villages. Once pregnant women had been identified through 
one of the two approaches above, study staff contacted the pregnant women in the community, 
and asked for informed consent in writing for the tuberculosis cohort study. This contact was 
used as a health education opportunity, an opportunity to describe the planned 
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epidemiological study, and the women were encouraged to have an attended delivery and to 
obtain BCG and other EPI vaccines for their children.  
During pre-delivery enrollment, as part of study procedures, the study staff attempted to 
determine the expected date of delivery (EDD). This was done through the use of the date of 
the pregnant woman’s last menstrual period (LMP) and/or the estimation of the fundal height 
by a study nurse, where the date of the LMP cannot be verified. A database was developed in 
to track of EDDs. The database was stored in a server with password-protected access to 
ensure confidentiality of participants’ record.  This system created an automatic alert for study 
staff 4 weeks before the EDD to contact VRs who reside in villages with potential upcoming 
deliveries. The VR’s were expected to be extra vigilant closer to the delivery date in order to 
notify the study staff within 72 hours of a pregnant woman giving birth. VRs were provided 
with a cellphone contact number with which to notify study staff once a delivery occurs; this 
was over and above the birth notification form they will fill as part of the HDSS. The time and 
date of notification was recorded by study staff and compared to when the birth notification 
was received by the HDSS. This was a quality control system to monitor the efficiency of the 
process of birth notification to the study and utilized for feedback to the VRs. Information on 
the study was provided during antenatal clinics.  
The main study was presented again to mothers after delivery either at home or in health care 
facilities (80% of deliveries in the study area occur at home, the majority attended by 
traditional birth attendants (TBAs). Two thousand nine hundred (2,900) healthy infants were 
enrolled. Since the majority of VRs were TBAs, notification of births to study staff was 
expected to be quite efficient. A home visit was conducted by study staff within 96 hours of 
delivery of the infant to administer standard Ministry of Health (MoH) BCG vaccine.  
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All infants born from consenting mothers who have been in Karemo and contiguous areas e.g 
Boro, Gem, etc. for at least one month were eligible for the study unless the parents stated that 
they intended to move from the area within the next year. Although the objective was to 
vaccinate all infants within 96 hours after birth, infants not vaccinated or vaccinated late were 
also enrolled and followed to evaluate the success of the aim of the study in reporting home 
deliveries and provision of BCG vaccination within 96 hours of birth, and since they 
contributed to TB incidence in the study area. All participants, regardless of when vaccinated, 
were entitled to the same services provided by this study. 
After birth notification, a team of nurses were dispatched on motor bikes to the same 
geographic area targeting several deliveries at a time whenever possible. Detailed instructions 
of the village and compound location were obtained from the DSS GIS data and the VRs and 
relayed to the vaccinating team. To improve the speed of identifying households, village 
reporters from villages with targeted enrollments were involved in identifying the actual 
households at enrollment. Contacts were made with health facilities providing maternity 
services in Karemo and contiguous areas e.g Boro, Gem etc. Once deliveries had occurred in 
a health facility, study teams were dispatched to enroll the infants. It was anticipated that for 
deliveries occurring at health facilities; those infants will be provided with BCG vaccination 
at the time of delivery (i.e. within 96 hours). The recruitment process was fine tuned by 
development of a recruitment study operating procedure (SOP) and improved overtime with 
the changes in recruitment strategies being tracked through different versions of the 
recruitment SOP. 
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3.7.3. Informed Consent 
A scripted informed consent was used to provide study information to the mother/parent or 
guardian. Signed informed consent to enroll the infant was obtained from the infant’s mother 
during pregnancy and reconfirmed after delivery. For women not enrolled during pregnancy, 
the consent process took place after delivery in the event of a live birth. During the informed 
consent process, the study staff confirmed with the parent/guardian that they understood the 
study before signing the consent form. In particular, it was determined that the infant’s 
parent/guardian understood that as part of study procedures, study staff would access and 
review the mother’s and the infant’s health records, including information on HIV. The risks 
and benefits section of the consent form was reviewed to ensure that the infant’s 
parent/guardian understood. If it was unclear that the parent/guardian never understood the 
consent form, the infant was not enrolled into the study but the parent was revisited after 2 
weeks by a study team member to review the consent form and ascertain his/her 
understanding of the study. Study staff kept track of the number of parents/guardians who 
withdrew consent after they were reminded of the above information and the study staff 
ensured they understood. If the parent/guardian indicated that s/he needed more time to think 
about his/her infant’s participation, the study staff made arrangements to visit him/her again. 
Infants of parents who required more time to think about study participation were referred for 
BCG vaccination at the nearest maternal child health (MCH) clinic. 
3.7.4. Enrollment and Baseline Evaluations 
No evaluations were performed before the written informed consent of the infant’s 
parent/guardian was obtained. All baseline evaluations either occured at home for infants born 
at home or within maternity child health units for infants born at health facilities. 
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All participants were assigned a study identification number (SIN).  At the time of BCG 
vaccination, information was collected by interview and health record inspection about: The 
infant’s birth (weight, length, head circumference, jaundice, birth information, etc.); BCG 
vaccination; Adults in the household who had TB or symptoms of TB; Parents’ demographic 
characteristics (gender, age, occupation, education); Maternal HIV/PMTCT status. 
This information was verified and additional information such as household size was obtained 
by interviewing mother or guardian. Information on HIV/PMTCT status of the mother/child 
was obtained from the antenatal card and from health facility maternity records. The 
parent/guardian was given information about TB and referred to the case verification ward 
(CVW) at Siaya District Hospital if the infant has symptoms, signs, or history of contact with 
an adult TB case.  
At the end of the baseline evaluation, all parents/guardians were given comprehensive health 
education for early diagnosis of TB symptoms in infants and advised to contact study staff or 
report to the Siaya District Hospital (SDH) CVW, if any of these symptoms occurred. The 
study handed over education material to the parents that described the relationship between 
TB and HIV, and explained that infants with HIV infection or malnutrition may have had a 
false TB negative infection response to the tuberculin skin test (TST). In addition, education 
and educational material was given to the parents describing the “early warning signs” of 
childhood illness (IMCI) and they were advised to seek health care by coming to study clinic 
should they detect any of the danger signs in their infant.  
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3.7.5. Participant Follow Up 
 
All participants were followed for a minimum of one year after enrollment and BCG 
vaccination, up until 2 years. During this time, four ways were used for all TB case 
surveillance (home visits, register review, self report and private sector) : 
3.7.5.1. Home visits 
 
Study staff arranged to meet mothers or guardians at the health facilities they routinely 
attended, every fourth month. If the mother never made it to the health facility, a study nurse  
carried out a home visit. Study staff made at least three attempts to visit the home of the infant. 
If the family had moved, neighbors were approached for directions to their new address. At 
each visit: The participant’s parent/guardian was asked: Whether any member of the 
household had symptoms of TB; Whether the participant had been hospitalized since the last 
visit ; Whether the participant had any household contact with an infectious case of TB in the 
last 2 years ; Whether the participant had an HIV test and whether they would like to be tested 
if they declined the last offer for testing. If previously tested, what was the result? The 
participant underwent a physical examination which included (Height, weight, head 
circumference, mid-upper arm circumference). Targeted examination for signs of TB e.g. 
enlarged, matted lymph nodes. All relevant clinical, demographic and contact details of the 
mother and infant were entered onto the case report form. At each visit, the participant’s 
parent/guardian were asked to contact the study office  or the VR in the event of their 
infant/child was diagnosed with TB, being admitted to hospital, sufferred a serious or life 
threatening illness or if their infant died.  
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3.7.5.2. Register review 
 
Documents were reviewed at the following institutions: TB registers at local TB clinics and at 
all health centers and hospitals in the study area (SCRH, Ng’iya Health Centre, Ting’wang’i 
Health Centre, Kadeng Ratuoro Health Centre, Nyangoma Kogelo Dispensary, Bar Olengo 
Community Centre) and at some hospitals outside the study area but within 50 km of Siaya 
District Hospital (Bondo District Hospital, Kisumu District Hospital and the Provincial 
General Hospital). Admission and discharge records at all hospitals, chest x-ray records, 
laboratory records (for those with positive smears who did not start treatment), the DSS IPD 
(In-patient department)/OPD (Out-patient department) registers and patient support center 
(PSC) records. The purpose of the review was to: To identify study participants diagnosed  
with TB at these facilities ; To identify study participants started on TB treatment at these 
facilities ; To retrieve and capture details of hospitalizations (including dates, length of stay 
and discharge diagnoses) ; To find individuals suffering from TB who are contacts of study 
participants by mapping their HDSS identification numbers (HDSS IDs) to households and 
seeing whether any of our enrolled infants resides in those households ; All participants 
identified with suspected or diagnosed TB or a history of contact were notified to the study 
field office and invited to the CVW to undergo further evaluation for TB. Every attempt was 
made to admit them to the CVW as early as possible after notification. 
 
As part of the HDSS, all in-patient and out-patient facilities in Karemo had ongoing pediatric 
in-patient (IPD) and out-patient (OPD) surveillance. This captured information including 
symptoms and signs of TB that was critical in catching missed TB cases that presented to 
those health facilities. Using HDSS IDs IPD/OPD data was searched to see whether any our 
participants had been to those facilities. Any participant discharged with a diagnosis of 
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HIV/AIDS, moderate or severe malnutrition or a lower respiratory tract infection e.g. 
pneumonia, bronchiolitis, etc. in the study area was followed up and examined weekly, to 
assess response to treatment: if the response was poor the infant was offered admission to the 
CV ward to exclude underlying tuberculosis.  
Study staff took note of those referred out of the study area and if referred to neighboring 
divisions or the Provincial General Hospital; every attempt was made to track those cases. 
Case notes and results of laboratory tests were collected and summarized. Referral to the 
nearest TB clinic for investigations for TB (sputum smear plus chest x-ray examination if 
indicated) was offered to any symptomatic household member of the family during follow-up 
visits every four months or to symptomatic mother/guardian during admissions at the case 
verification ward. 
3.7.5.3. Self Report 
 
In between regularly scheduled follow-up and unscheduled visits, contact was maintained 
with the participants’ parents/guardians to ensure prompt follow-up of study participants in 
the event that they experience an illness, symptoms of TB, or have TB diagnosed in a 
household member (i.e. TB suspects for CVW admission). At the time of the participant’s 
enrollment, each parent/guardian was given a “phone card” with the telephone number of the 
study office printed on the back for use in such a circumstance. In addition, the village 
reporters or other study staff contacted the participant’s parent/guardian to follow-up on the 
participant, or during a well-baby visit at a health center.  
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3.7.5.4. Private Sector 
 
Area medical practitioners and hospital personnel were sensitized about the study, and 
contacted regularly by staff to review their records to check whether any participating infant 
presented with symptoms or signs suggestive of TB disease. 
3.7.6. Mortality surveillance, determining cause of death, severity and 
causal relationship 
 
At enrollment, mothers of infants were informed of the need that should their infant die, to 
determine the cause of death accurately and were asked to contact study staff as soon as 
possible if a death occurred. Relevant staff at all hospitals, clinics and mortuaries and other 
individuals who might find out about an infant’s death shortly after it occurred were asked to 
contact a study team member about the death. The study team determined whether the 
deceased infant was a study participant. Any participant enrolled into the study discovered 
dead would have the following done, if possible: All relevant case notes accessed from 
hospitals, clinics or private practitioners copied and evaluated by a study clinical officer for 
cause of death. A copy of the participant’s death certificate and autopsy report, if performed, 
obtained, and evaluated by a study clinical officer for cause of death. (Pathological autopsies 
are seldom performed in this population). As part of the HDSS, a “verbal autopsy” 
questionnaire was administered to the primary caregiver (or a family member where the 
primary caregiver was not accessible) at least four weeks after death. This was evaluated by 
two HDSS clinical officers for cause of death using a standardized algorithm. In the case of 
disagreement, a third HDSS clinical officer/medical officer was used. In addition, study 
clinical officers from this study performed additional reviews of verbal autopsy forms for all 
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study infants in order to further confirm these reviews. Referral to the nearest TB clinic for 
investigations for TB (sputum smear plus chest X-ray examination if indicated) was offered to 
any household member of the deceased participant who was symptomatic. 
3.7.7. Schedule of Participant Evaluations  
 
All participants were assigned a study identification number (SIN) were followed up 
according to the protocol unless consent for follow-up was withdrawn. The sponsors and 
local/international regulatory bodies were notified of any deviations from protocol visits or 
evaluations and these evaluations, if applicable, were rescheduled or performed at the nearest 
possible time to the original schedule. 
3.7.8. HIV counseling and testing 
 
HIV counseling and testing was routinely offered to all mothers in the study area during 
pregnancy, during labour or post delivery. This was facilitated through the US President’s 
Emergency Plan For AIDS Relief in Africa (PEPFAR). Provider initiated HIV testing and 
counseling (PITC) and HIV care and treatment facilities were available in Karemo in Ng’iya 
Health Centre, Ting’wang’i Health Centre, Nyangoma Kogelo Dispensary, Bama Nursing 
Home (BNH) and Bar Olengo Community Centre, which doubled as TB treatment facilities. 
At SCRH, there was a voluntary counseling and testing (VCT) center which served as an 
alternative testing site for those reluctant to have PITC at recommended sites. Furthermore, 
the PEPFAR program initiated home-based, door to door HIV testing in the study area in 
2008.  
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For this study, consent was obtained prior to conducting HIV testing. If a mother was enrolled 
during pregnancy, the study nurse enquired whether she had been tested in the two months 
preceding the day of the interview. If the result was negative and the test done more than 2 
months prior to the interview date, the study nurse encouraged her to go to her nearest PITC 
or VCT center for re-testing. If the result was positive, she was given information on PMTCT, 
advised on the health benefits of hospital delivery and referred to the nearest PSC for care.   
 
If enrollment was done during or shortly after delivery and the mother had not been tested for 
HIV in the previous 2 months, she was referred for HIV testing and if the result is positive, 
she was given nevirapine in labour, where possible, and the infant was given a single dose of 
nevirapine within 72 hours. If the mother has been tested for HIV in the previous 2 months 
and the result was positive, she was supplied with nevirapine to take at the onset of labour, 
and to give to her infant within 72 hours of birth.  
 
All infants exposed to maternal HIV were referred to a patient support centre in order to 
receive AZT for 4 weeks, cotrimoxazole throughout the breastfeeding period; and the mothers  
were adequately advised on safe infant feeding practices. All mothers of infants enrolled in 
the study were asked to bring the infants to SCRH for HIV PCR at 6 weeks of age. If an infant 
was enrolled after discharge from the hospital or at home, included in the consent form, 
permission was sought to extract information on PMTCT status from the health facility 
maternity records. Participant privacy and confidentiality was assured at all times, and special 
care taken to ensure the privacy of the HIV counseling process and the confidentiality of the 
data. All parents of infants were told about the HIV care and treatment services available at 
SDH and in their area and encouraged to seek them. Linkages were formed with PSCs to 
check whether parents and infants referred for care reached the referral points.  
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3.7.9. TB treatment and follow-up of TB diagnoses  
For infants, if a diagnosis of active TB was made, the case was reported to the Ministry of 
Health’s Division of Leprosy, Tuberculosis and Lung Disease (DLTLD) via the County 
Tuberculosis and Leprosy Coordinator (CTLC) based at the SCRH. Treatment was started at 
the hospital and parents/guardians were given a two-week supply of anti-TB medication, 
following the treatment guidelines of the DLTLD, instructed to contact their nearest treatment 
center, and given a referral letter. Study staff notified the respective treatment centre and 
followed up the patient up to ensure that s/he subsequently reported to the referral center. If a 
study participant was diagnosed with TB in another health facility, the infant was offered 
admission to the SCRH CVW for further investigations and to obtain sputum for culture.  
Study staff abstracted from the TB register and recorded in study documents, as applicable, 
whether treatment was started, what treatment was prescribed, the date it was started, the date 
it was stopped and the treatment outcome. Outcomes will be recorded using the standard 
WHO DOTS program definitions of cured, completed, failure, default, transferred out and 
died. Study staff assisted the clinics to trace any treatment defaulters and conduct home visits 
to assess outcome. 
3.7.10. Laboratory Procedures 
 
Induced sputa and gastric lavage specimens were digested using Nalc/NaOH and concentrated 
for better yield by centrifugation. Smears were prepared and read using the FM microscopy 
technique to identify AFB. Digested sputa were inoculated into solid culture, Lowenstein 
Jensen (LJ) and liquid culture (MGIT 960) media. Detailed instructions for laboratory 
procedures were developed separately in standard operating procedures. Isolates of positive 
cultures were kept and subjected to drug susceptibility testing and fingerprinting if new 
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funding becomes available. Through collaboration with San Raffaele Scientific Institute, 
Supranational Reference Laboratory (SRL), Milan, Italy; quality assurance and quality control 
were ensured through proficiency panel testing. At the initial stages of the project; inactivated 
TB bacteria were shipped to the SRL for spoligotyping and DNA finger printing. The SRL’s 
support included feed back on cross contamination based on the list of samples handled at 
given periods during the study. All positive cultures will be speciated by PCR to exclude 
disease caused by non-tuberculous mycobacteria (NTM) and BCG disease.  
3.7.10.1. Specimen collection  
 
Detailed instructions for specimen management, including collection, processing, storage, 
shipment and infection control, were developed separately in a Specimen Management 
section of the standard operating procedures.  
3.7.10.2. Specimen Storage 
 
After processing, if the relevant consent had been received, aliquots of sputum specimens 
were stored at Kisian KEMRI CGHR TB Laboratory in a -70
0
C freezer for up to 20 years 
after completion of the study. During storage, the samples were delinked from participant 
identifiers (anonymized). These specimens may be used in the future to carry out other tests 
for TB or conditions related to TB, including HIV, if new funding becomes available. 
Separate IRB approval will be sought for any such future evaluations. 
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3.7.10.3. Routine Laboratory Evaluations 
 
Study participants suspected of having TB were referred for diagnostic procedures which 
included some or all of the following: HIV-1 rapid test and HIV-1 PCR test ; two serial early 
morning induced sputum specimens and two serial early morning gastric lavage specimens for 
detection of acid fast bacilli (AFB) by fluorescent microscopy and for culture for M. TB; their 
household members who are symptomatic were referred to neighboring TB diagnostic 
facilities for further workup and HIV counseling and testing. 
3.7.11. Safety considerations 
3.7.11.1. Adverse Events 
 
Since there was no experimental pharmaceutical product being administered in this study, 
there was no formal safety surveillance. However, adverse reactions may occur during clinical 
procedures such as sputum induction e.g. bronchospasm or TB skin testing e.g. ulceration. 
The onset and resolution times and dates of each event and the action taken in response to the 
reaction was documented. All serious adverse events were closely monitored and reported to 
the IRB/ERC. Expected adverse events included: Infant deaths due to non-TB causes (HIV, 
malaria, ARI, tetanus, diarrheal disease, etc.) (250 deaths expected - 8.9%) ; Infant deaths due 
to TB ; BCG disease following BCG vaccination (fewer than 1 case expected). 
Study-related Adverse Events included: Bronchospasm during sputum induction and local 
reactions to tuberculin testing. 
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3.7.12. Completion of Study and Loss to Follow-up 
 
Enrolled infants were considered to have completed the study if followed up between 1 year 
upto a maximum of 2 years. It was specified on the case report form whether or not the 
participant completed the study follow-up procedures. Interim participant status was noted per 
protocol. A participant were considered lost to follow-up if: three or more documented 
attempts to contact the participant were made without success, and/or the participant was 
confirmed to have moved from the study area and was not traceable and/or no contact was 
established by the time the study was completed such that there was insufficient information 
to determine the participant’s status depending on enrollment period. At this time, a 
documentation of lost to follow-up was entered on this participant’s Study Completion CRF. 
All attempts were made to trace participants who moved out the study area and they were 
only be labeled as lost to follow up if they were untraceable. Investigators documented 
attempts to re-establish contact with missing participants throughout the study period. If 
contact with a missing participant was re-established, follow-up was resumed according to the 
protocol. 
3.7.13. Final Study Visit 
 
At the final visit, all parents/guardians were given information about TB and informed of the 
need to seek treatment if they or their infant developed symptoms or signs of TB. All 
parents/guardians were asked if the participant had any episode of TB during the study. 
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3.7.14. Statistical Considerations 
 
The sample size for this study was calculated using current birth estimates in the target 
population. The total population in the study area was estimated by the time as 181,272 with 
80% of births taking place at home. The infant mortality rate was estimated to be 86/1000 
(Ref, MOH data, Siaya District 2007). Assuming a 5 percent exclusion rate and 15% refusal 
rate, the enrollment target for this study is 2,900 infants (~3600 X 80%). The estimated 
annual notification rate of total TB (all types) is 440/100,000 (0.4%) among the general 
population. The annual incidence of culture-positive TB among infants less than 1 year of age 
is expected to be 0.5% based on experience at another African site. Given 2900 infants, a 95% 
confidence interval for the above would be 0.5% (0.29%, 0.85%) based on a binomial 
approximation. 
Most successful strategies for recruiting infants into the tuberculosis cohort study assessing 
the methodologies employed and BCG profiles (vaccination at time of enrollment, effort time 
taken to vaccinate infants, vaccinations percentages for cohort) will be tabulated. Of interest 
also is to draw a flow chart that describes the recruitment numbers and percentages from 
notifications, deferrals, refusals, screenings, consents, ineligible and enrolled. Loss to follow-
up (at 6 weeks and four monthly visits), withdrawals, deaths and retention will also be 
included in the flow chart.  Reasons for screen failures and ineligible will also be documented. 
Recruitment and enrollment numbers by month and year are also graphically represented to 
monitor the trends with time. 
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3.7.15. Baseline Demographics and Other Characteristics 
 
Case report forms (CRFs) designed for collection of information that was saved into the study 
database. Potential infants and their parents/guardians were screened prior to enrollment to 
establish eligibility. The following information was gathered from the parents/guardians: 
weight (≥ 1700 grams) changed to kilograms in subsequent analysis; source of knowing about 
the study (village reporter, antenatal clinic, other – specify). From enrollment CRFs: date of 
enrollment was recorded and used to calculate ages of infants, fathers and mothers from 
provided dates of births if known. Housing type (mud, semi-permanent, permanent, other). 
Mother’s occupation (subsistence farming, commercial farming, salaried worker, small 
business e.g. sell maize, business owner e.g. duka or shop, skilled laborer e.g., carpenter, 
unskilled laborer e.g. construction worker; fishing; not working; housewife. Father’s 
occupation (subsistence farming, commercial farming, salaried worker, small business e.g. 
sell maize, business owner e.g. duka or shop, skilled laborer e.g., carpenter, unskilled laborer 
e.g. construction worker; fishing; not working. Level of education obtained by parents – 
mother and father (none, primary, secondary, tertiary or unknown). How many living brothers 
and sisters does this child have? (0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, >10). Birth details; place of 
birth (hospital, traditional birth attendants, home, other). Numbers of babies born (1, 2, 3). 
Sex of Baby (Male, Female). Infant’s estimated gestational age at birth (in weeks). Baby’s 
weight in grams. Baby’s length at birth in centimeters. Was it a difficult delivery (yes or no). 
If yes state which one, prolonged labor, fits before giving birth, mother had febrile illness at 
the time of giving birth or the waters broke ≥ β4 hours before delivery. Maternal TB and HIV 
status: Did the mother have oral thrush during the last one year (Yes or No)?  Has the mother 
been tested for HIV in the last 2 months (Yes or No)? What was the result? (Positive or 
Negative). If negative (and tested greater than 2 months before) or not tested, refer for repeat 
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test or test respectively. If mother referred for test; result of HIV antibody test: Positive, 
negative or not done. Did mother receive ARVs during pregnancy? (Yes or No). Did mother 
receive ARVs during labor? (Yes or No). Did child receive ARVs within 3 days of birth? 
(Yes or No). Has the mother been diagnosed with TB during the last one year? (Yes or No). If 
yes, is she currently on treatment? (Yes or No). How long has she been on treatment? (≤β 
weeks or ≥β weeks). Is Isoniazid prophylaxis needed for the baby? (Yes or No). BCG 
vaccination status: Date of BCG vaccination, Time of BCG vaccination, Not vaccinated, 
reasons for not receiving vaccination (parent declined, baby too sick, other – specify). Inform 
mother, the baby will be tested for HIV using PCR at 6 weeks of age. Baby given 
appointment for 6 week HIV PCR test (Yes or No). Name of clinic or facility where sample 
for HIV PCR collected. Appointment for delivering HIV PCR results scheduled (Yes or No). 
HIV PCR results (Positive, Negative or Not done). 
 
Follow-up CRFs collected the following information: Was this study visit completed? Yes or 
No. If No, reason why not (Consent annulment/ withdrawal, Loss to follow up, Moved out of 
study area, Died). Date of follow-up visit. Does the child currently have any of the following 
signs or symptoms? Yes or No. If yes, check the following (Cough ≥ β weeks, Fever ≥β 
weeks, Night sweats ≥β weeks, Wheeze≥β weeks, Failure To Thrive, Loss of appetite, 
Unusual fatigue or weight loss (maternal assessment). If any of the above symptoms is ticked, 
schedule a case verification ward admission and notify the follow-up and clinical 
coordinators. Since the last visit, has s/he been taken to any clinic other than for vaccines and 
well baby visit? Yes or No. If yes, what was the diagnosis / reason for visit: Pneumonia, 
Bronchiolitis, Malnutrition, HIV/AIDS or Other – specify. If infant referred to the case 
verification ward for TB Diagnostic workup. What is the infant‟s HIV status (Positive, 
Negative or unknown). If negative or unknown and 18 months, request for HIV PCR. Result 
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of infant PCR (Positive, Negative or Not done). If negative or unknown and >18 months of 
age, request for HIV antibody test. Result of HIV antibody test (Positive, Negative, or Not 
done). Household TB Contact Details: Is there anyone living in the same household as the 
child have any TB symptoms? No or Yes. If yes, How many? 1 person, more than 1 person or 
unsure. 
Is the person suffering from TB in the household currently on TB treatment? Yes or No. If 
yes, does s/he take it everyday? Yes or No. Where does s/he collect the treatment? SDH, 
Ng‟iya, Akara, Kadenge, Ting‟wang‟I, Kogelo Nyang’oma. Which date did s/he start taking 
TB treatment? If there was any history of TB contact, refer to the case verification ward. 
 
Overall status of the child: Child is well and there is no history of TB contact (“W”); Child is 
well but there is a history of TB contact (“C”); Child has symptoms +/ signs of TB but no 
history of TB contact (“S”); Child has symptoms +/ signs of TB and a history of TB contact 
(“CS”); Child on TB treatment (“TB Rx”); Child on INH prophylaxis or Child has died (“D”). 
 
TB Referral: After last visit: Has your child been in the CV ward? Yes or No. Was s/he 
diagnosed with TB? Yes or No. With this visit: Has the child been booked into Siaya District 
Hospital CV ward for TB diagnosis? Yes or No. TB Diagnostic Evaluation/CV Ward. 
 
Information from referral letter/mother: How did we find out this child might have TB? 
Routine home visit day; Hospital records; Self report; Private, mission, NGO sector report. 
Has the child been diagnosed with TB? Yes, No or Unsure. Has the child been started on TB 
treatment? Yes, No or Unsure. Has the child been started on Isoniazid prophylaxis? (Yes, No 
or Unsure). 
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Case verification Ward Admission: Which date was infant admission? How many times has 
this child been admitted to the CV ward before? (0, 1, 2 or 3). History from the Road to 
Health Card. RTH Card seen (Yes or No). Comment on the child's growth. (Good, Danger, 
Very dangerous or No RTHC). Length baby was breastfed in (months). Is baby still 
breastfeeding? (Yes or No). Has your child been coughing more than usual during the last 
month? (No or Yes); How many days  if more than 7 days how many wks or Unsure. Has 
your child been wheezing more than usual during the last month? (No or Yes); How many 
days  if more than 7 days how many wks or Unsure. Has your child been having breathing 
difficulties? (No or Yes); How many days  if more than 7 days how many wks or Unsure. If 
yes does you child have fast breathing? (No or Yes); How many days  if more than 7 days 
how many wksor Unsure.  
 
Does your child have in-drawing of the chest while breathing? (No or Yes); How many days  
if more than 7 days how many wks or Unsure. If yes, has your child received treatment? (No 
or Yes); How many days  if more than 7 days how many wks or Unsure. If yes, is the child‟s 
breathing getting better with treatment? (No, Yes or Unsure). 
 
Has your child been hot to touch more than usual during the last month? (No or Yes); How 
many days  if more than 7 days how many wks or Unsure. Has your child been sweating at 
night more than usual during the last month? (No or Yes); How many days  if more than 7 
days how many wks or Unsure.  
 
Has your child been growing well? (Gaining weight, not gaining not losing, losing weight or 
don't know). Has your child lost weight? (Yes or No). Has your child been eating more poorly 
than usual during the last month? (No or Yes); If yes, how many days  if more than 7 days 
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how many wks or Unsure. Has your child been tired (decreased playfulness) more than usual 
during the last one month? (No or Yes); If yes, how many days  if more than 7 days how 
many wks or Unsure. Have you taken your child to any health facility due to any of the above 
symptoms? (No or Yes). If yes, which health facility? State the facility. 
  
TB contact details: Is there anyone living in the same household as your child whom you 
think may have TB or may have had TB in the last year? (No or Yes). If yes, 1 person, more 
than 1 person or unsure. What is the relationship of the main person with TB to your child? 
[i.e. the person mentioned above who has the most contact with the child]. (Mother, Father, 
Sibling, Granny, Grandpa, Child, Other family, other person (not family) or not applicable 
(NA). Is the person suffering from TB in the household currently on TB treatment? (Yes or 
No). If yes, does s/he take it regularly? (Yes or No). Where does s/he collect the treatment? 
State the health facility.  
 
HIV status: What your infant‟s HIV status? Positive, negative or unknown. If negative or 
unknown and 18 months, request for HIV PCR. Result of infant PCR: Positive, Negative or 
not done. If negative or unknown and >18 months of age, request for HIV antibody test. 
Result of HIV antibody test: Positive, Negative or not done. 
 
General Information and Examination; Weight in kilograms. Height in centimeters. Mid upper 
arm circumference [MUAC] in centimeters. Head circumference in centimeters. Oedema, 
(Present or Absent). Status of participant: Well and there is no history of TB contact (“W”). 
Well but there is a history of TB contact (“C”). Has symptoms +/ signs of TB but no history 
of TB contact (“S”). Has symptoms +/ signs of TB and a history of TB contact (“CS”). Was 
diagnosed with TB infection? Was diagnosed with TB disease? If the participant was a 
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confirmed TB case, where was it first diagnosed? (Study team through the CVW; Public 
health care facility; Private health care facility; Verbal autopsy). How was the TB case 
detected? Through: (Study screening and specimen collection, DSS surveillance (Verbal 
Autopsy), IPD/OPD surveillance, Self/VR referral. Participant status: On TB treatment, 
Defaulted, Lost to follow-up (date of last contact below), Withdrew Consent (fill in date of 
withdrawal below), Death (fill in death details below) (“D”). Date of last contact and date of 
withdrawal.  
 
Baseline demographics of the participants (infant) and parents’ demographic characteristics 
were selected from the information collected using the CRFs (e.g, infant sex (male or female), 
infant age (calculated by subtracting enrollment date (year, month and day) from date of bith 
(year, month and day), age of parents (calculated by subtracting enrollment date (year, month 
and day) from date of bith (year, month and day), mothers’ occupation (subsistence farming, 
commercial farming, salaried worker, small business, business owner, skilled laborer, 
unskilled laborer, fishing, not working, housewife), place of residence (generated by looking 
at places of origin to categorize as HDSS (Gem, Asembo or Karemo) or non-HDSS area 
(Boro), attendance of unscheduled visits ((infants who attended unscheduled visits for sick 
infants versus those who did not turn up for unscheduled visits), mother’s education (none, 
primary, secondary, tertiary or unknown), type of housing (mud, semi-peermanent or 
permanent), place of birth (home or health facility), place of enrollment (at home, traditional 
birth attendant,health facility or other place where infant was born), mother’s HIV status 
(positive, negative or not done), mother’s attendance of antenatal care (yes or no), numbers of 
infants delivered (singletons, twins or triplets), number of mother’s other children (other 
siblings i.e. 1-10 and >10) and infant’s weight at birth (grammes was converted) was 
summarized for all participants in two frequency tables for infant and maternal characteristics.   
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Fathers were excluded in the selection of variables because of scant information collected 
from their spouses. Housing type was collapsed into three categories i.e., mud, semi-
permanent and permanent. Mother occupation was collapsed into five categories i.e., farming 
(subsistence and commercial farming), salaried worker, business (small business and business 
owner) and laborer (unskilled and skilled laborers). Maternal education was collapsed into 
four categories i.e., none, primary, secondary and tertiary. Infant place of birth was collapsed 
into home and health facility. Number of infants born was categorized into singletons and 
twins. Age was calculated in days for infants. Birth weight was converted to kilogrammes. 
Number of other siblings of infant by mother was categorized into ≤ γ and > γ children to 
describe family size. Mother’s HIV status was classified into two variables i.e., positive and 
negative. Mother’s age was calculated in years. Detailed Variables description, codes, values 
and names are in Table 20 in the appendices section page 130. Average duration of study 
follow-up (time from enrollment to study completion, death, or withdrawal of consent) was 
calculated for all participants.  Number (percentage) of participants who left the study area 
was summarized.  Reason for outmigration, as available, was presented by key demographic 
parameters, and for all participants.  In addition, missing data will be included in the 
frequency tables.  
3.7.16. Statistical Analyses 
 
Baseline demographics of the infant and parents’ demographic characteristics were collected 
and summarized by frequency and corresponding percentages for categorical variables and 
descriptive statistics (median, IQR) where applicable. Bivariate analysis was performed using 
Pearson’s chi-square test (p-values) whereas logistic regression was done using backward 
elimination to study the effect of co-variates on outcome of interest to get a parsimonious 
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model. Considering follow-up as an event of interest, time to being lost to follow-up was 
calculated and explored using Kaplan-Meier curves and the difference between the curves 
determined using log-rank test for binary variables and Generalized Wilcoxon test for > 2 
variables.   
The outcome in logistic regression analysis is coded as 0 or 1, where 1 indicates that the 
outcome of interest is present, and 0 indicates that the outcome of interest is absent. We 
defined p as the probability that the outcome is 1; the multiple logistic regression model can 
be formulated as follows: 
                                                               
Where    is the expected probability that the outcome is present; X1 through Xp are distinct 
independent variables; and b0 through bp are the regression coefficients to be estimated from 
the model. 
A proportional hazard model (Cox (1972)) defined as: 
                           
Where       is the unspecified baseline hazard function at time t, X= (         ) are the 
explanatory/predictor variables and    are the regression coefficients for the ith individual. 
3.7.17. Assessment of Objectives 
3.7.17.1. Analysis of Objectives 
 
Characterize recruitment and enrollment activities to document notifications, prescreening 
and screening outcomes prior to enrollment by way of a flow chart illustrating numbers and 
percentages as appropriate. A graphical representation of recruitments and enrollments by 
month and year to assess the trends over the study period. Tabulate recruitment strategies used 
in the study and profile BCG vaccinations at enrollment, effort time taken to vaccinate and 
evaluate vaccination status post-enrollment. Run frequencies for infant and maternal 
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characteristics to tabulate distribution. Assess distribution of infant and maternal 
characteristics (infant age at birth in days, infant birth weight in kilogrammes and maternal 
enrollment age in years). 
 
Factors associated with place of delivery (home versus health facility) was analysed using 
maternal variables (education, occupation, housing type, received antenatal care, HIV status, 
number of children mother has of her own, place of residence, mother’s age). This analysis 
was carried out using logistic regression for crude and adjusted odds ratios.  
 
Factors associated with loss to follow up was analyzed using infant variables (place of 
enrollment, place of birth, infant sex, number of infant delivered, attendance of unscheduled 
visits, birth weight, infant age at enrollement and maternal variables (education, occupation, 
housing type, attendance of antenatal care, HIV status, number of children mother has of her 
own, place of residence, mother’s age).  Plot Kaplan Meier estimates of significant variables. 
 
A descriptive analysis of signs, symptoms, clinical impressions and investigations 
documented during the unscheduled visits for infants enrolled in the tuberculosis cohort study. 
Frequencies, interquartile ranges (IQRs) and means were ran as applicable. A graphical 
representation of unscheduled visits by day of the week. An evaluation of prescriptions 
dispensed to infants during unscheduled visits. Tabulate suspects, TB cases and deaths 
identified from unscheduled visits. 
 
Factors associated with unscheduled visit attendance (yes versus no) was analyzed using 
infant characteristics (place of enrollment, place of birth, infant sex, number of infant 
delivered, unscheduled visits, birth weight, infant age) and maternal characteristics (maternal 
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education, maternal occupation, housing type, mother’s receipt of antenatal care, HIV test 
status, number of children mother has of her own, place of residency and maternal age). These 
analyses were carried out using logistic regression for crude and adjusted odds ratios. 
3.7.17.2. Participant Populations 
 
All infants enrolled in the study were used in the analysis of the primary objective and in all 
exploratory or supportive analyses. A separate sub-analysis for mothers of infants was carried 
out to assess the relationship of maternal variables with study objectives. 
3.7.17.3. Computer Methods 
 
Statistical analysis was performed using STATA 12.0 under a Windows operating system. 
3.7.18. Data Collection and Monitoring 
 
A detailed description of how data was collected and monitored is provided in summary is as 
follows : Source documents included infant medical records, TB registers, HIV 
registers/clinic records, HDSS verbal autopsy data, out-patient surveillance data, inpatient 
surveillance data and study documents. Data was captured onto personal digital assistants 
(PDAs), laptops or paper case report forms (CRFs). Data collected on PDAs were uploaded to 
laptop computers and later transferred into the study database. Paper CRFs were checked and 
scanned, and the data verified and then exported to the main database. The study database was 
stored on a server on a secure network with nightly backup at the KEMRI CGHR offices in 
Kisian. Programmatic edit checks facilitated data cleaning and generate data queries for 
discrepant values. Data was evaluated and stored in such a way as to maintain confidentiality 
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of infants and their families. All study records are kept secured for a minimum of 5 years 
following the completion of the study. The investigator permitted study monitors to access the 
network server location where the entered data and all study-related documents are stored.  
3.7.19. Human Subjects 
3.7.19.1. Ethics and Regulatory Considerations 
 
The study was conducted according to the Declaration of Helsinki, ICH-GCP, local regulatory 
requirements, Protection of Human subjects (21 CFR 50), Institutional Review Boards (21 
CFR 56), and Obligations of Clinical Investigators (21 CFR 312). The protocol and informed 
consent form were reviewed and approved by the Institutional Review Boards (IRBs) or 
Independent Ethics Committees (IECs) of  the participating clinical site (Center for 
Respiratory Diseases Research (CRDR) Scientific Committee (SC) ; Kenya Medical Research 
Institute (KEMRI) Scientific Steering Committee (SSC) and Kenya Medical Research 
Institute (KEMRI) ERC ; Centers for Disease Control and Prevention (CDC) IRB and IRB 
used by the Aeras Global TB Vaccine Foundation (Aeras). The investigator regularly 
informed the IRB/IEC on the progress of the study, at minimum once a year. Aeras had an 
independent IRB review and approval of the protocol and informed consent form and kept the 
IRB informed of the progress of the study. Written informed consent was obtained from each 
participant prior to any protocol-specified procedures being conducted. To maintain 
confidentiality, study ID numbers were used to identify the participant’s laboratory specimens 
and study documents. All study records were maintained in a secured location. Clinical 
information was not released without written permission from the participant except as 
necessary for monitoring or auditing of the study by Aeras or its designee or applicable 
regulatory authorities.  
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3.7.19.2. Institutional Review Board or Independent Ethics 
Committee 
 
All the documents the IRB/IEC needed to fulfill its responsibilities, such as the protocol, 
protocol amendments, information concerning participant recruitment, payment or 
compensation procedures, etc., were submitted to the IRB/IEC by the investigator. The 
IRB’s/IEC’s written, unconditional approval of the study protocol and the informed consent 
form were in the possession of the investigator/clinical site staff prior to the conduct of any 
protocol-specified procedures. Modifications to the protocol were not implemented without 
prior written IRB/IEC approval (the Kenya Medical Research Institute (KEMRI) scientific 
steering committee (SSC) and the IRB’s/IEC’s of KEMRI, CDC and Aeras) except when 
necessary to eliminate immediate hazards to the participants or when the modification 
involves only logistical or administrative aspects of the study. Such logistical or 
administrative modifications were submitted to the IRB/IEC in writing by the investigator, 
and a copy of the correspondence to verify the submission was maintained. Documentation of 
IRB/IEC approval was sent to the sponsor immediately upon receipt. The investigator 
informed the IRB/IEC of any modifications to the informed consent form or any other 
documents previously submitted for review/approval and of any new information that 
adversely affected the safety of the participants or the conduct of the study, and provided an 
annual update with or without a request for re-approval, and advised the IRB/IEC when the 
study has been completed. Any documents or forms provided to the participant (e.g., 
information cards, form letters from the investigator), and all forms of study advertising 
(flyers, brochures, print advertisements, radio or television scripts, etc.) were approved by the 
IRB/IEC prior to the documents or forms being provided to any participant.  
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3.7.19.3. Informed Consent 
 
Informed consent was obtained in accordance with the current edition of the Declaration of 
Helsinki and ICH-GCP prior to any protocol-specified procedures being conducted. Informed 
consent was documented in writing on a consent form approved by the IRB/IEC. All relevant 
information was provided in both oral and written form in a way that is understandable to the 
participant’s parent/ guardian. Ample time and opportunity was given for the participant’s 
parent/ guardian to inquire about details of the study. The written consent document embodied 
the elements of informed consent as described in the Declaration of Helsinki and complied 
with local regulations. The investigator or the investigator’s qualified designee explained the 
nature of the study and informed the participant’s parent/ guardian that participation was 
voluntary and that they could withdraw the participant at any time. The participant’s parent/ 
guardian were informed about the study’s purpose including why the participant was selected 
to participate, the goals of the study, the expected benefits and risks of participating, including 
unforeseeable risks. The individual was provided with a description of the procedures and the 
estimated duration of time required to participate in the study, as well as alternative 
interventions or courses of treatment, if applicable. The participant’s parent/ guardian 
received an explanation as to whether any compensation and any medical treatments are 
available if injury occurs and, if so, what they are, where further information may be obtained, 
and whom to contact in the event of a study-related injury. Individuals were told whom to 
contact for answers to any questions related to the study. All parents and guardians of 
participants were informed that their child’s participation was voluntary and that they were 
free to withdraw them from the study for any reason at any time without penalty or loss of 
benefits to which they are otherwise entitled. The extent of the confidentiality of participant 
records was defined and the participant’s parent/ guardian informed that applicable data 
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protection legislation applied. The parents and guardians of participants were informed that 
monitor(s), auditor(s), IRB/IEC members, and the applicable regulatory authorities may be 
granted direct access to the participant’s original study medical records for verification of 
protocol-specified procedures and/or data, without violating the confidentiality of the 
participant to the extent permitted by the applicable laws and regulations. The participant’s 
parent/ guardian were informed that his/her signature on the informed consent form indicated 
that s/he has decided to participate in the study, having read and discussed the information 
presented. All parents or guardians were be told that they may withdraw from the study at any 
time. Any such withdrawal was fully documented by the study site.  The original, signed 
informed consent form for each participant was maintained by the investigator as part of the 
participant’s study records. A copy of the signed informed consent form was provided to each 
participant’s parent/ guardian. 
3.7.20. Relationship with Regional Health Services in the study 
area 
3.7.20.1. Study awareness 
 
The regional and local TB control program staffs were made aware of the study and their 
assistance sought in raising general awareness of and support for the study. This was done 
through the regional and district TB and HIV coordinators. 
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3.7.20.2. Treatment of infants with latent TB infection 
 
The policy of the Kenyan Division Leprosy, Tuberculosis and Lung Disease (DLTLD) is to 
offer treatment for latent infection to individuals under the age of 5 years. Those found to be 
infected but with no evidence of active disease were offered isoniazid therapy. 
3.7.20.3. Treatment of children with TB 
 
Those who have microbiological or other evidence of TB were prescribed the standard TB 
treatment regimen recommended by the DLTLD and the WHO. TB treatment and care is 
available free of charge in all public sector facilities in this community. 
3.7.21. Management of TB suspects  
 
Those infants with symptoms and/or signs of TB or a history of contact with a TB case were 
referred to the case verification ward (CVW) at SCRH for further investigations. The results 
of the investigations were communicated in writing to the parent/guardian and to the nearest 
TB clinic. The parent/guardian was given a referral letter to take the infant to the nearest 
public sector TB treatment clinic. The results of smears and cultures were reported to the 
DLTLD. Symptomatic members of the family were referred to the nearest TB treatment clinic 
for sputum smears, chest x-rays and treatment if found to have TB. 
3.7.22. Compensation and incentives  
 
The study reimbursed the costs of transportation for the parent/guardian of infants attending 
the study clinic, admission to the CVW at the SCRH according to distance travelled from 
home to central clinic. It ranged from Kenya Shillings (KES) 300-500 (€ β.5-4.2). The study 
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provided a small incentive to mothers of children admitted to the CVW in the form of 
mother/baby products, the value did not exceed KES 500 (€ 4.β) upon discharge. Infants were 
enrolled at home, clinics or hospitals by study nurses. Recruitment teams were issued with 
blocks of study identification numbers (SIN). If an infant is eligible for the study, individual 
written parental consent was obtained. Infants were screened by study staff to assess 
eligibility for entry into the study. A master log was maintained of all screened infants. On 
enrollment day (study day 0), the investigator confirmed that the participant met all eligibility 
criteria. Only infants whose parent/guardian had signed an informed consent and who met 
eligibility criteria were enrolled into the study. A participant was considered to be entered into 
the study upon assignment of a SIN.  
3.7.23. Confidentiality 
 
Every effort was made to keep the infants’ study records strictly confidential, in particular 
results of HIV test results. To maintain confidentiality, all laboratory specimens, evaluation 
forms, reports and other records were identified by a coded number and participant’s initials 
only. All study records were kept in a locked filing cabinet and code sheets linking a 
participant’s name to a study identification number was stored separately in another locked 
filing cabinet. Clinical information was not be released without the written permission of the 
participant’s parent/ guardian, except as necessary for monitoring by the relevant regulatory 
agency or the sponsor of the clinical trial. In regard to the intended use of fingerprinting 
technology, fingerprint readers pose no greater threat to confidentiality than issuing a study 
participation card with the study ID on it to a research participant and much less threat to 
confidentiality than a card with name or picture on it; such a card had already been approved 
for use in the HDSS. The principal investigator also complied with all applicable privacy 
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regulations (e.g. Health Insurance Portability and Accountability Act of 1996, EU Data 
Protection Directive 95/46/EC). 
3.7.24. Expected application of the results 
 
An assessment of recruitment, loss to follow-up and morbidity among infants enrolled in an 
infant tuberculosis cohort study will inform the planning and conduct of future vaccine trials. 
Elicit a better understanding of the epidemiology of TB in infants from populations with a 
high burden of HIV. Establish better understanding of recruitment and follow-up of infants 
into TB research. Describe morbidity patterns of infants in this cohort during the 1-2 years 
follow up to inform planning of pediatric studies and trials.  
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4. Results 
4.1. Recruitment outcomes, accrual trends and baseline characteristics of 
infants enrolled into TB cohort study 
4.1.1. Notifications, recruitment and retention of infant cohort 
 
Community entry process began in February 2009 where stakeholders from the Ministry of 
Health and staff, Provincial Administration and 159 village reporters, 20 CAB members, 20 
administrative officials were engaged. Community meetings and ongoing community 
mobilization activities drove the recruitment of potential participants and subsequent 
enrollment of infants into the cohort study. Strong collaborations were established with 
maternal child health clinics and hospitals providing antenatal care, preganancy delivery and 
post natal care services.  
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Figure 3 shows that the study approached 3225 infants as would-be potential study 
participants. During pre-screening exercise, 78 were identified as ineligible and of these 
ineligible, 55/78 (71%) had plans to move out of study area followed by over age infants 7/78 
(9%), early neonatal death 5/78 (6%), mother sick 4/77 (5.2%), non-resident 3/77 (3.9%), still 
birth 2/77 (2.6%) and other reasons that were not listed by respondents. Infants found to be 
eligible were 3147. When subjected to study screening, 109 deferred for various reasons, 
mostly noted to consult their spouses or family at home and 127 refused participation in the 
study whereas 2911 were screened and eligible for consenting for study participation. Eleven 
were found ineligible with reasons identified as low birth weight 9/11 (82%), abnormal head 
circumference 1/11 (9%) and cleft plate 1/11 (9%). The study enrolled 2900 infants into the 
tuberculosis cohort. Study follow up was 1-2 years depending of time of enrollment. Upon 
enrollment into the study, infant withdrawals were 38/2900 (1.3%) and infant deaths were 
13/2900 (0.7%) before or as at 6 week visit. Loss to follow up before or as at at 6 week visit 
was 117/2849 (4.1%). Retention as at 6 week visit was 2732/2849 (95.9%). We also assessed 
infant study participation during the four monthly follow up visits that took place after the 6 
week visit to end of study. We found that withdrawals were 105/2732 (3.8%) and deaths were 
192/2732 (7.0%) whereas loss to follow up was 99/2435 (4.2%). Retention during four 
monthly follow up visits was 2336/2435 (95.9%). Overall study retention having incorporated 
infants seen during unscheduled visits was 2336/2552 (91.5%).  
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Table 2. Recruitment mode and BCG vaccination profiles of enrolled infants 
Infant cohort recruitment strategy  N (3147) % 
Village Reporter 3104 98.6 
Health Facility Staff 28 0.9 
Other 15 0.5 
 
Infant BCG immunized at enrollment visit N (2900) % 
Yes 719 24.8 
No 1803 62.2 
Missing 378 13.0 
 
BCG vaccination effort time N (2900) % 
Within 96 hours 365 12.6 
After 96 hours 1340 46.2 
Already vaccinated 719 24.8 
Notification time missing 476 16.4 
 
BCG Vaccination status post-enrollment N (2900) % 
Yes 2510 86.6 
No 390 13.4 
 
The study employed two main recruitment strategies that utilized notifications through village 
reporters 3104/3147 (98.6%) and health facility staff 28/3147 (0.9%). We also found out that 
there were mothers who were informed about the study through other means such as snowball 
effect where a mother of an already infant 18/3147 (0.6%) informed a potential mother about 
the infant study. The study staff verified the road to health card to ascertain whether the 
infants had received BCG vaccination or not. The verification revealed that infants who had 
received BCG vaccination were 719/2900 (24.8%) and those who had not received BCG 
vaccination were 1803/2900 (62.2%). There were infants 378/2900 (13%) whose verification 
cards were not available. The study had a target to vaccinate enrolled infant within 96 hours. 
Efforts to achieve this target were ; within 96 hours 365/2900 (12.6%) and after 96 hours 
1340/2900 (46.2%) whereas we had 719/2900 (24.8%) had already received BCG 
vaccinations by the time the nursing teams arrived at infant home or health facility and 
476/2900 (16.4%) whose notification times were not recorded.  BCG vaccination status was 
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reviewed after study efforts to assist vaccination infants not yet vaccinated and found that 
2510/2900 (86.6%) were BCG vaccinated and 390/2900 (13.4%) had no records to verify 
vaccination status post enrollment. Thirty-five percent of birth notifications were enrolled 
within 96 hours of receiving the information of birth, we hypothesize that this was attributable 
to many of the infants being delivered at home and partially, lack of involvement of men 
during recruitment (Table 2). 
4.1.3. Recruitment and accrual trends 
 
Birth notifications were received in the study from April 2009 and recorded upto June 2010. 
The study protocol was amended in December 2009 to extend study area following decreased 
accrual in the months of October to December 2009. January 2010 recorded the highest 
notification followed by September 2009 and March 2010. The study reported high 
enrollments in the months of April 2010, May 2010 and September 2009. A study team 
comprising of nurses and community health workers met village reporters at designated areas 
to visit the mother who had delivered. We targeted to enroll 2900 infants within 1 year though 
the study extended slightly with a month having enrolled the first infant on 25th May 2009 
and enrolled the last infant on 28th June 2010 owing to the initial challenges the study faced 
in accruing infants into the study. 
Initially, the recruitment strategy at this time was that the Recruitment Supervisor received all 
the notifications in a centralized approach then channeled this communication to the field and 
nursing teams to facilitate a visit where study information was shared, BCG vaccinations 
administered if not yet done and locator information taken. The centralized approach was not 
able to handle the numerous notifications that were received via mobile phone. It slowed 
down the enrollment numbers as the individual manning the phone verified details of the 
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notifications before releasing a team of nurses and filed workers. One of the things the study 
sought during this drop in recruitment and enrollment activities was an amendment to extend 
the study area to cover other areas contiguous to the study area. The other adjustment was to 
devolve the recruitment and enrollment activities to the nursing and field teams to reduce the 
turn around in responding to directly to notifications from community based workers referred 
to as ‘Village Reporters’. These changes were responsible for the high numbers recorded in 
January 2010. Considerable efforts were put in place to educate the community on the 
objectives of the study and reasons behind targeting healthy infants; the highest notifications 
were recorded in January 2010 following a protocol amendment that extended the study area 
to include contiguous regions. The amendment was initiated after noting a decline in 
notifications between October - December 2009. Initially, the study sought to recruit pregnant 
mothers by informing them about the study with a follow up visit thereafter after delivery but 
this was logistically challenging due to personnel time and costs incurred in the two visits 
prior to delivery and post-delivery. The study team amended the recruitment standard 
operating procedure (SOP) to drop approaching pregnant mothers and only focus on 
notifications of mothers who had successfully delivered. Some of the challenges faced during 
recruitment period included communication bottlenecks between study team and community 
health workers as ownership of personal mobile phones was very low and therefore depended 
upon relatives or neighbours to relay birth notifications to the study; some terrains in the study 
area were hard to penetrate or access during rainy seasons experienced around March to May 
(long rains) and October to December (short rains) where we recorded decreased notifications 
and enrollments; motorbike riders in the study were slapped with a speed limit control (30 
kilometers/hour) due to an increase in road accidents involving study motorbikes in the study 
area; birth notifications were at times fewer than expected such as May, June and November 
of 2009. 
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Figure 5, is a graphical presentation of recruitment and enrollment by month and year. There 
was a sustained increase in the recruitment and enrollment activities from April 2009 to 
September 2009 and thereafter, in October 2009 the study started experiencing a continual 
decrease in recruitment and enrollment efforts until December 2009.  The highest recruitment 
months were January 2010 (334), September 2009 (296), March 2010 (296), July 2009 (234) 
and February 2010 (231). The highest enrollment months were April 2010 (286), March 2010 
(267), September 2009 (257), January 2010 (252) and May 2010 (251) respectively.  
4.1.4. Distribution of infants by age in days 
 
Majority of infants enrolled into the cohort were aged 0-9 days as captured in histogram 
(Figure 5). Range of infant age at enrollment was 0-66 days old. There was an outlier (infant 
aged 66 days) in the cohort. Infant cohort had a population distribution skewed (1.369) to the 
left. Distribution is skewed to the left with a mean age of 11.72 days with 51 infants were 
classfied as outliers between 43-60 days as study targeted to enroll 0-6 week olds. 
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Characteristics of infants enrolled into the study were as follows: majority of enrollments 
were carried out in the homes; more deliveries took place at home than health facility; male 
infants were more than females; most of the infants were delivered as singletons and over 
three-quarters of infants attended unscheduled visits (Figure 6a, 6b, 6c, 6d, 6c). Home 
enrollments 2801/2900 (96.7%) compared to health facilities 97/2900 (3.3%) when place of 
enrollment was assessed. Place of birth was evaluated and we found that 1837/2900 (63.9) 
and 1038/2900 (36.1%) were born at home and health facilities respectively. Infant sex at 
birth were recorded as 1488/2900 (51.3%) and 1412/2900 (48.7%) being males and females 
respectively. Number of children delivered as singletons were 2810/2900 (96.9%) and those 
delivered as twins were 90/2900 (3.1%). Infants brought for unscheduled visits were 
2251/2900 (77.6%) while 649/2900 (22.4%) did not participate in unscheduled visits (Table 
3).  
Table 3. Infant characteristics in the tuberculosis cohort study (N=2900) 
Variable  Frequency Percent 
Place of Enrollment 
Home  
Health Facility 
Missing 
 
2801 
97 
2 
 
96.7 
3.3 
Place of Birth 
Home 
Health Facility 
Missing 
 
1837 
1038 
25 
 
63.9 
36.1 
Infant Sex 
Male 
Female 
 
1488 
1412 
 
51.3 
48.7 
Infants Delivered 
Singleton 
Twin 
Unscheduled visit attendance 
Yes 
No 
 
2810 
90 
 
2251 
649 
 
96.9 
3.1 
 
77.6 
22.4 
 
 
 
 

75 
 
received antenatal care; HIV infected mothers were 14%; over 50% of mothers had family 
sizes < 3 children; about 58% of mothers in the cohort had no HDSS identification or lived 
outside the HDSS area (Figure 8a, 8b, 8c, 8d, 8e, 8f, 8g).  Education status showed that 
mothers without education were 105/2828 (3.7%), those with primary education were 
2319/2828 (82%), those with secondary education were 365/2828 (12.9%) and those with 
tertiary education were 39/2828 (1.4%). Maternal occupation revealed that farmers were 
1033/2828 (36.5%), salaried workers were 1637/2828 (57.9%), businesswomen were 68/2828 
(2.4%), laborers were 70/2828 (2.5%) and fishmongers were 20/2828 (0.7%). Housing types 
where mothers resided were as follows; those residing in mud houses were 1877/2900 
(66.4%), those residing in semi-permanent housing were 524/2828 (18.5%) and those living 
in permanent houses were 421/2828 (14.9%). Uptake of antenatal care (ANC) clinic visits 
was assessed and we found that mothers who received ANC clinics were 2521/2828 (89.1%) 
compared to 287/2828 (10.2%) who never attended ANC clinics. HIV testing was provided 
and the outcome was as follows; 393/2791 (14.1%) were HIV positive, 1941/2791 (69.5%) 
were HIV negative whereas 457/2791 (16.4%) opted out and non testers. The study evaluated 
family size and established that in this cohort, mothers with < 3 children were 1491/2828 
(52.7%) versus mothers with ≥ γ children who totaled 1337/2828 (47.3%) (Table 4). 
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Table 4. Maternal characteristics in the tuberculosis cohort study (N=2828) 
Variable  Frequency Percent 
Maternal Education 
None  
Primary 
Secondary 
Tertiary 
 
105 
2319 
365 
39 
 
3.7 
82.0 
12.9 
1.4 
Maternal Occupation 
Farming 
Salaried worker 
Business 
Labor 
Fishing 
 
1033 
1637 
68 
70 
20 
 
36.5 
57.9 
2.4 
2.5 
0.7 
Housing Type 
Mud 
Semi-permanent 
Permanent 
Other 
 
1877 
524 
421 
6 
 
66.4 
18.5 
14.9 
0.2 
Received Antenatal Care 
Yes 
No 
Unverifiable 
HIV status 
Positive 
Opted-out 
Negative 
 
2521 
287 
20 
 
393 
457 
1941 
 
89.1 
10.2 
0.7 
 
14.1 
16.4 
69.5 
Mother other children 
<3 children 
≥ γ children 
Residency 
HDSS 
Non-HDSS 
 
1491 
1337 
 
1201 
1627 
 
52.7 
47.3 
 
42.5 
57.5 
   
Interquartile range (IQR) for infant age in days (4, 17); infant weight in grams (2900, 3700) 
and maternal age in years (20.3, 29.9) (Table 5). 
Table 5. Infant and maternal characteristics summarized in percentiles 
 
Variable N p25 p50 p75 
Infant Age (days) 2900 4 8 17 
Infant Weight (grams) 2900 2900 3300 3700 
Mother Age (years) 2828 20.3 25.3 29.9 
 
 
Table 4, summarises infant age in days as follows; 25th percentile was 4 days, 50th percentile 
was 8 days and 75th percentile was 17 days. Infant weight in kilograms (kgs) analyzed as 
follows; 25th percentile was 2.9 kgs, 50th percentile was 3.3kgs and 75th percentile was 
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3.7kgs. Maternal age in years (yrs) was as follows; 25th percentile was 20.3 yrs, 50th 
percentile was 25.3 yrs and 75th percentile was 29.9 yrs. 
4.2. Factors associated with place of delivery among mothers in 
tuberculosis cohort 
 
Maternal characteristics analyzed by place of delivery using bivariate and logistic regression 
to look at maternal characteristics associated with choice of delivery place. Bivariately, 
maternal occupation : farming, odds ratio (OR)=6.14, 95% confidence interval (CI) [3.56, 
10.57] ; salaried worker, OR=4.5, 95% CI [2.63, 7.7] ; fishing, OR=3.29, 95% CI [2.1, 18.66] 
versus labor. Housing type : mud, OR=4.39, 95% CI [3.51, 5.48] ; semi-permanent, OR=2.65, 
95% CI [2.03, 3.46] versus permanent. Mothers receiving antenatal care, OR=0.19, 95% CI 
[0.13, 0.28] versus mothers who did not receive antenatal care. HIV positive status, OR=0.64, 
95% CI [0.51, 0.79] versus HIV negative status. HDSS residency, OR=1.42, 95% CI [1.22, 
1.67] versus non-HDSS residency and mother age, OR=1.04, 95% CI [1.03, 1.06] were 
associated with place of delivery. Lack of education, primary, secondary levels of education 
versus tertiary ; mothers involved in business as an occupation versus labor and family size 
(≥γ children) versus < γ children were not statisically associated with place delivery (Table 5). 
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Table 6. Maternal characteristics by place of delivery (health facility versus home) 
      COR* AOR** 
Variable  Health Facility 
Delivery n (%) 
Home Delivery 
n (%) 
OR 95% (CI) P value OR 95% (CI) P value 
Mother Education (N=2803)         
None 24 (23.1) 80 (76.9) 61.7 (13.84, 274.77) 0.469 16.28 (3.51, 75.59) <.0001 
Primary 746 (32.4) 1553 (67.6) 38.5 (9.26, 160.22) 0.396 13.6 (3.16, 58.54) <.0001 
Secondary 207 (57.3) 154 (42.7) 13.8 (3.27, 57.98) 0.858 6.16 (1.42, 26.72) 0.015 
Tertiary 37 (94.9) 2 (5.1) Ref  Ref  
Mother Occupation (N=2803)         
Farming 311 (30.4) 711 (69.6) 6.14 (3.56, 10.57) <.0001 2.66 (1.41, 5.02) 0.002 
Salaried worker 606 (37.3) 1017 (62.7) 4.5 (2.63, 7.7) <.0001 2.57 (1.37, 4.82) 0.003 
Business 40 (58.8) 28 (41.2) 1.89 (0.92, 3.84) 0.084 1.57 (0.69, 3.56) 0.278 
Fishing 6 (30.0) 14 (70.0) 3.29 (2.1, 18.66) 0.001 4.08 (1.26, 13.17) 0.019 
Labor 51 (72.9) 19 (27.1) Ref  Ref  
Housing Type (N=2797)         
Mud 535 (28.8) 1322 (71.2) 4.39 (3.51, 5.48) <.0001 3.23 (2.52, 4.13) <.0001 
Semi-permanent 209 (40.1) 312 (59.1) 2.65 (2.03, 3.46) <.0001 2.08 (1.56, 2.78) <.0001 
Permanent 268 (64.0) 151 (36.0) Ref  Ref  
Mother Received Antenatal Care (N=2783)         
Yes 973 (39.0) 1523 (61.0) 0.19 (0.13, 0.28) <.0001 0.21 (0.14, 0.31) <.0001 
No 31 (10.8) 256 (89.2) Ref 
 
Ref 
 HIV test status (N=2783)       
Positive 177 (45.3) 214 (54.7) 0.64  (0.51, 0.79) <.0001 0.78 (0.48, 1.29) 0.332 
Negative 827 (34.6) 1565 (65.4) Ref  Ref  
Number of children mother has of her own 
(N=2803) 
        
>= 3 children 478 (36.2) 844 (63.8) 1 (0.86, 1.17) 0.985 0.68 (0.39, 1.20) 0.185 
< 3 children 536 (36.2) 945 (63.8) Ref  Ref  
Residency (N=2803) 
        HDSS 377 (31.6) 818 (68.4) 1.42 (1.22, 1.67) <.0001 1.49 (0.65, 3.42) 0.344 
Non HDSS 637 (39.6) 971 (60.4) Ref  Ref  
Mother Age     1.04 (1.03,1.06) <.0001 0.99 (0.95, 1.04) 0.728 
* Crude Odds Ratio 
** Adjusted Odds Ratio 
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Multivariate logistic regression: No maternal education, OR=16.28, 95% CI [3.51, 75.59], 
maternal primary education, OR=13.6, 95% CI [3.16, 58.54], maternal secondary education, 
OR=6.16, 95% CI [1.42, 26.72] versus maternal tertiary education ; mothers engaged in 
farming, OR=2.66, 95% CI [1.41, 5.02], mothers employed as salaried workers, OR=2.57, 95% 
CI [1.37, 4.82], mothers engaged in fishing, OR=4.08, 95% CI [1.26, 13.17] versus mothers 
working as laborers ; mothers living in mud type of housing, OR=3.23, 95% CI [2.52, 4.13], 
mothers living in semi-permanent housing, OR=2.08, 95% CI [1.56, 2.78] versus mothers 
living in permanent type housing and mother receipt of antenatal care, OR=0.21, 95% CI 
[0.14, 0.31] versus mothers non-receipt of antenatal care (Figure 9). 
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4.3. Predictors of loss to follow up  
4.3.1. Infant characteristics by loss to follow up versus retained 
 
Infant characteristics of loss to follow up by bivariate and multivariate analyses. Bivariate 
analyses established that: home delivery, OR=0.76, 95% CI [0.57, 1.00] versus health facility 
delivery ; a unit increase in infants birth weight and age respectively implied that both were 
statistically significant. However, if place of enrollment was at home, male infants, being 
born as singletons, and attendance of unscheduled visits were not associated with LTFU were 
not associated with LTFU in bivariate and mutlivariate analysis (Table 6 and Figure 10). 
Table 7. Infant characteristics by LTFU versus retained 
 
      OR* AOR** 
Variable LFTU  
n (%) 
Retained  
n (%) 
COR 95% (CI) P 
value 
AOR 95% (CI) P value 
Place of Enrollment (N=2551)        
 Home  207 (8.4) 2255 (91.6) 0.82 (0.40, 1.65) 0.571 1.02 (0.45, 2.30) 0.969 
Health Facility 9 (10.1) 80 (89.9)  Ref  Ref  
Place of Birth (N=2530)        
 Home 125 (7.7) 1492 (92.3) 0.76 (0.57, 1.00) 0.054 0.70 (0.51, 0.96) 0.026 
Health Facility 91 (10.0) 822 (90.0) Ref  Ref  
Infant Sex (N=2552)        
 Male  111 (8.5) 1201 (91.5) 1.00 (0.76, 1.32) 0.995 0.86 (0.63, 1.17) 0.343 
Female 105 (8.5) 1135 (91.5) Ref  Ref  
Number of infants delivered 
(N=2552) 
       
 Singleton 208 (8.4) 2262 (91.6) 0.85 (0.40, 1.79) 0.669 2.07 (0.72, 5.94) 0.174 
Twins 8 (9.8) 74 (90.2) Ref  Ref  
Unscheduled Visits         
Attended 108 (8.7) 1129 (91.3) 0.82 (0.60, 1.12) 0.210 0.81 (0.59, 1.10) 0.180 
Did not attend 75 (10.4) 643 (89.6) Ref  Ref  
Birth Weight - - 0.66 (0.53, 0.83) <.0001 0.72 (0.54, 0.97) 0.032 
Age - - 0.97 (0.96, 0.99) 0.001 0.99 (0.97, 1.12) 0.118 
* Crude Odds Ratio (COR) 
**Adjusted Odds Ratio (AOR) 
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Multivariate logistic regression: home delivered infants, OR=0.70, 95% CI [0.51, 0.96] 
versus health facility delivered infants ; infant birth weight, OR=0.72, 95% CI [0.54, 0.97] ; 
mothers engaged in farming, OR=0.35, 95% CI [0.17, 0.74] (Figure 10).  
 
4.3.2. Maternal characteristics by loss to follow up versus retained 
 
Maternal characteristics of loss to follow up by bivariate and multivariate analyses. These 
analyses revealed that mothers engaged in farming activity OR=0.27, 95% CI [0.14, 0.52] 
and mothers who are salaried OR=0.31, 95% CI [0.16, 0.59] versus laborers ; mothers living 
in mud type of housing OR=0.46, 95% CI [0.33, 0.66] versus mothers living in permanent 
housing and mothers living within the HDSS OR=2.00, 95% CI [1.51, 2.65] versus mothers 
not residing within the HDSS were significant bivariately whereas maternal education, 
receipt of antenatal care, HIV status, number of children mother has of her own and mother 
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age were not statistically significant. Maternal education ; mothers engaged in businesses and 
fishing ; mothers residing in semi-permanent type of housing ; mothers receipt of antenatal 
care ; HIV status ; place of residency and maternal age were not associated with loss to 
follow up (Table 7).   
 
4.3.3. Separation or combining of infant and maternal characteristics 
by LTFU versus retained 
 
An assessment of the strategy to decide whether to separate or combine infant and maternal 
characteristics was carried out by analyzing both models and the following was established: 
The combined model lost a significant amount of sample size of about 450. The combined 
model had four maternal characteristics that were statistically significant variables i.e., 
housing type (mud), housing type (semi-permanent), HDSS residency and mother’s age. 
None of the infant characteristics were statistically signficant. In the literature review, the 
tendency was to separate the two models as distinct to understand individual characteristic 
contribution to the outcome of interest. Our exploratory analysis supports the strategy used in 
literature of studies evaluated. 
 
In the separate model, infant characteristics: place of birth and birth weight were statistiscally 
significant whereas maternal characteristics: occupation (farming and salaried worker), 
housing type (mud) and number of children mother has (≥ γ children) were statistically 
significant. The difference between the two models i.e. combined is that combined has no 
infant characteristics that are significant and shows that housing type (semi-permanent) is 
statistically significant whereas for separate model, infant characteristics (place of birth and 
birth weight) were significant.
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Table 8. Maternal characteristics by LFTU versus retained 
  
Variable 
    COR* AOR** 
LFTU n (%) Retained n (%) OR 95% (CI) P value OR 95% (CI) P value 
Maternal Education (N=2480)         
None 3 (3.1) 95 (96.9) 0.22 (0.05, 1.05) 0.057 0.49 (0.95, 2.53) 0.395 
Primary 157 (7.7) 1875 (92.3) 0.59 (0.20, 1.69) 0.323 1.25 (0.38, 4.05) 0.712 
Secondary 51 (16.0) 267 (84.0) 1.34 (0.45, 3.98) 0.601 2.31 (0.71, 7.46) 0.162 
Tertiary 4 (12.5) 28 (87.5) Ref  Ref  
Mother Occupation (N=2480)         
Farming 68 (7.3) 862 (92.7) 0.27 (0.14, 0.52) <.0001 0.35 (0.17, 0.74) 0.006 
Salaried worker 120 (8.4) 1306 (91.6) 0.31 (0.16, 0.59) <.0001 0.38 (0.19, 0.77) 0.008 
Business 13 (24.5) 40 (75.5) 1.10 (0.46, 2.65) 0.832 0.84 (0.33, 2.18) 0.724 
Fishing 1 (7.1) 14 (92.9) 0.26 (0.03, 2.18) 0.215 0.27 (0.03, 2.37) 0.237 
Labor 13 (22.8) 44 (77.2) Ref  Ref  
Housing Type (N=2475)         
Mud 119 (7.0) 1573 (93.0) 0.46 (0.33, 0.66) <.0001 0.49 (0.33, 0.73) <.0001 
Semi-permanent 47 (10.8) 386 (89.2) 0.75 (0.49, 1.15) 0.183 0.72 (0.46, 1.13) 0.153 
Permanent 49 (14.0) 301 (86.0) Ref  Ref  
Mother Received Antenatal Care (N=2460)         
Yes 192 (8.7) 2016 (91.3) 0.90 (0.58, 1.41) 0.660 0.87 (0.55, 1.39) 0.558 
No 24 (9.5) 228 (90.5) Ref 
 
Ref 
 HIV test status (N=2808)       
Positive 34 (9.7) 315 (90.3) 1.14  (0.78, 1.68) 0.493 1.01 (0.75, 1.35) 0.962 
Negative 182 (8.6) 1929 (91.4) Ref  Ref  
Number of children mother has of her own (N=2828)         
> =3 children 105 (8.9) 1075 (91.1) 1.06 (0.80, 1.40) 0.699 2.26 (1.67, 3.05) <.0001 
< 3 children 110 (8.5) 1190 (91.5) Ref  Ref  
Residency (N=2828)  
       ***HDSS 122 (12.0) 898 (88.0) 2.00 (1.51, 2.65) <.0001 1.24 (0.83, 1.86) 0.292 
Non HDSS 93 (6.4) 1367 (93.6) Ref  Ref  
Mother Age - - 1.00 (0.98,1.02)  0.932 0.93 (0.97, 1.02) 0.824 
* Crude Odds Ratio (COR) 
** Adjusted Odds Ratio (AOR) 
***Health and Demographic Surveillance System (HDSS)  
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Mutlivariate analyses showed that mothers engaged in farming OR=0.35, 95% CI [0.17, 0.74], 
mothers working as salaried workers OR=0.38, 95% [0.19, 0.77] versus mothers working as 
laborers. Mothers living in mud type of housing OR=0.49, 95% CI [0.33, 0.73] versus 
mothers living in permanent type of housing and mothers with ≥ γ children OR=β.β6, 95% CI 
[1.67, 3.05] versus < 3 children were statistically significant. Maternal characteristics by 
LTFU versus retained showed that mothers employed as salaried workers, OR=0.38, 95% CI 
[0.19, 0.77] versus mothers working as laborers ; mother living in mud type of housing, 
OR=0.49, 95% CI [0.33, 0.73] versus mothers living in permanent type housing and mothers 
with ≥ γ children, OR=β.β6, 95% CI [1.67, γ.05] versus mothers with < γ children (Table 7 
and Figure 11). 
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Additionally, Cox Proportional hazards analysis was carried out to assess the risk of LTFU 
by infant and maternal characteristics (Tables 8 and 9 respectively). 
 
Table 9. Infant characteristics by LTFU using Cox Proportional Hazards 
 
  
Variable LFTU  
n (%) 
*HR 95% (CI) P value 
Place of Enrollment (N=2551)    
 Home  207 (8.4) 0.71 (0.31, 1.62) 0.198 
Health Facility 9 (10.1) Ref  
Place of Birth (N=2530)    
 Home 125 (7.7) 0.74 (0.51, 1.08) 0.118 
Health Facility 91 (10.0) Ref  
Infant Sex (N=2552)    
 Male  111 (8.5) 0.78 (0.55, 1.13) 0.198 
Female 105 (8.5) Ref  
Number of infants delivered 
(N=2552) 
   
 Singleton 208 (8.4) 1.60 (0.38, 6.73) 0.520 
Twins 8 (9.8) Ref  
Birth Weight - 1.26 (0.57, 2.77) 0.565 
Age - 1.01 (0.99, 1.03) 0.059 
* Hazards Ratio (HR) 
 
 
      None of the infant characteristics were found to be statistically significant by Cox 
Proportional Hazards (Table 8 and Figure 13). 
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Table 10. Maternal characteristics by LFTU using Cox Proportional Hazards 
 
  
Variable 
  HR* 
LFTU n (%) HR 95% (CI) P value 
Maternal Education (N=2480)     
None 3 (3.1) 1.67 (0.31, 8.97) 0.550 
Primary 157 (7.7) 0.74 (0.17, 3.31) 0.697 
Secondary 51 (16.0) 1.15 (0.25, 5.18) 0.857 
Tertiary 4 (12.5) Ref  
Mother Occupation (N=2480)     
Farming 68 (7.3) 0.50 (0.18, 1.42) 0.195 
Salaried worker 120 (8.4) 0.98 (0.38, 2.57) 0.981 
Business 13 (24.5) 1.07 (0.28, 4.16) 0.923 
Fishing 1 (7.1) 0.90 (0.10, 8.03) 0.926 
Labor 13 (22.8) Ref  
Housing Type (N=2475)     
Mud 119 (7.0) 0.54 (0.34, 0.84) 0.007 
Semi-permanent 47 (10.8) 0.57 (0.33, 1.01) 0.054 
Permanent 49 (14.0) Ref  
Mother Received Antenatal Care (N=2460)     
Yes 192 (8.7) 1.11 (0.51, 2.45) 0.789 
No 24 (9.5) Ref 
 HIV test status (N=2808)    
Positive 34 (9.7) 0.88 (0.49, 1.63) 0.701 
Negative 182 (8.6) Ref  
Number of children mother has of her own 
(N=2828) 
    
> =3 children 105 (8.9) 0.91 (0.62, 1.32) 0.606 
< 3 children 110 (8.5) Ref  
Residency (N=2828)  
   ***HDSS 122 (12.0) 0.53 (0.34, 0.82) 0.004 
Non HDSS 93 (6.4) Ref  
Mother Age - 0.95 (0.93, 0.99) 0.015 
* Hazards Ratio (HR) 
 
Infant and maternal variables were analysed using Cox Proportional Hazards to evaluate 
factors associated with LTFU only. Maternal characteristics that were significant were: 
Mothers living in mud type of housing, Hazards Ratio (HR)=0.54, 95% CI [0.34, 0.84] versus 
mothers living in permanent housing; Residing within the HDSS, HR=0.53, 95% CI [0.34, 
0.82]. A unit increase in maternal age, HR=0.95, 95% CI [0.93, 0.99] (Table 9). 
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Maternal characteristics that were significant were: Mothers living in semi-permanent houses, 
mothers living in mud houses, mothers residing within the HDSS and a unit increase of 
maternal age had a decreased risk for LTFU (Figure 14). 
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5. Factors influencing attendance of unscheduled visits in the infant 
tuberculosis cohort study 
 
Table 11. Infant characteristics by unscheduled visits (yes vs. no) 
 
      COR* AOR** 
Variable Unscheduled visits OR               95% (CI)       P value         OR        95% (CI)              P value 
Yes                No 
n (%)           n (%) 
Place of Enrollment (N=2898)        
 Home  628 (22.4) 2173 (77.6) 0.90 (0.54, 1.48) 0.676 0.84 (0.51, 1.40) 0.504 
Health Facility 20 (20.6) 77 (79.4)  Ref  Ref  
Place of Birth (N=2875)        
 Home 387 (21.1) 1450 (78.9) 1.21 (1.01, 1.45) 0.035 1.22 (1.01, 1.46) 0.036 
Health Facility 254 (24.5) 784 (75.5) Ref  Ref  
Infant Sex (N=2900)        
 Male  306 (20.6 1182 (79.4) 1.04 (0.87, 1.24) 0.686 1.00 (0.84, 1.20) 0.970 
Female 299 (21.2) 1113 (78.8) Ref  Ref  
Number of infants delivered 
(N=2900) 
       
 Singleton 627 (22.3) 2183 (77.7) 1.20 (0.73, 1.94) 0.468 1.21 (0.73, 2.00) 0.453 
Twins 23 (25.6) 67 (74.4) Ref  Ref  
Residency (N=2900)         
HDSS 565 (23.3) 1859 (76.7) 1.40 (1.08, 1.80) 0.009 0.08 (0.04, 0.13) <.0001 
Non-HDSS 85 (17.9) 391 (82.1) Ref  Ref  
Birth Weight (N=2900) - - 0.92 (0.80, 1.05) 0.210 0.64 (0.82, 1.15) 0.731 
Age (N=2900) - - 0.99 (0.98, 0.99) 0.027 0.99 (0.98, 1.00) 0.105 
*Crude Odds Ratio (COR) 
** Adjusted Odds Ratio (AOR) 
 
        
Infant and maternal variables were analysed to evaluate factors associated with unscheduled 
visit attendance. Infants born at home OR=1.21, 95% CI [1.01, 1.45] versus infants born at 
health facility; Infants residing in HDSS OR=1.40, 95% CI [1.08, 1.80] versus infants 
residing outside the HDSS area and a unit increase in age OR=0.99, 95% CI [0.98, 0.99] were 
bivariately associated with unscheduled visits. Multivariate analyses revealed that infants 
delivered at home OR=1.22, 95% CI [1.01, 1.46] versus infants delivered in health facility; 
infants residing in HDSS OR=0.08, 95% CI [0.04, 0.13] versus infants residing outside the 
HDSS were associated with unscheduled visits (Table 10 and Figure 15).  
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Table 12.Maternal characteristics by unscheduled visits (yes vs. no) 
      COR* AOR** 
Variable Unscheduled visits OR 95% (CI) P value OR 95% (CI) P value 
No 
n (%) 
Yes 
n (%) 
Maternal Education (N=2830)         
None 22 (21.2) 82 (78.8) 3.02 (1.36, 6.67) 0.006 2.65 (1.11, 6.28) 0.027 
Primary 480 (20.7) 1842 (79.3) 3.10 (1.63, 5.93) 0.001 2.89 (1.40, 5.94) 0.004 
Secondary 112 (30.6) 254 (69.4) 1.84 (0.93, 3.61) 0.079 1.81 (0.87, 3.75) 0.111 
Tertiary 17 (44.7) 21 (55.3) Ref  Ref  
Mother Occupation (N=2830)         
Farming 201 (19.4) 836 (80.6) 1.89 (1.08, 3.18) 0.024 1.08 (0.59, 1.97) 0.799 
Salaried worker 391 (23.9) 1243 (76.1) 1.42 (0.84, 2.41) 0.192 0.94 (0.52, 1.68) 0.828 
Business 16 (22.9) 54 (77.1) 1.51 (0.71, 3.22) 0.289 1.21 (0.55, 2.70) 0.636 
Fishing 2 (9.5) 19 (90.5) 4.24 (0.91, 19.90) 0.067 2.72 (0.56, 13.08) 0.212 
Labor 21 (30.9) 47 (69.1) Ref  Ref  
Housing Type (N=2824)         
Mud 393 (20.9) 1491 (79.1) 1.50 (1.18, 1.91) 0.001 1.23 (0.95, 1.59) 0.122 
Semi-permanent 116 (22.3) 404 (77.7) 1.38 (1.02, 1.85) 0.034 1.19 (0.88, 1.63) 0.262 
Permanent 119 (28.3) 301 (71.7) Ref  Ref  
Mother Received Antenatal Care (N=2810)         
Yes 564 (22.3) 1962 (77.7) 1.03 (0.77, 1.38) 0.830 1.10 (0.81, 1.48) 0.547 
No 65 (22.9) 219 (77.1) Ref 
 
Ref 
 HIV test status (N=2810)       
Positive 75 (19.2) 316 (80.8)   (0.43, 0.79) <.0001 0.69 (0.50, 0.95) 0.023 
Negative 554 (22.9) 1865 (77.1) Ref  Ref  
Number of children mother has of her own (N=2830)         
> =3 children 311 (23.3) 1025 (76.7)  (0.92, 1.32) 0.305 1.16 (0.95, 1.41) 0.142 
< 3 children 320 (21.4) 1174 (78.6) Ref  Ref  
Residency (N=2830)  
       HDSS 241 (20.0) 964 (80.0) 1.26 (1.05, 1.51) 0.012 1.15 (0.95, 1.39) 0.153 
Non HDSS 390 (24.0) 1235 (76.0) Ref  Ref  
Mother Age (N=2830) - - 1.02 (1.01, 1.03)  0.003 1.02 (1.00, 1.03) 0.026 
* Crude Odds Ratio (COR) 
**Adjusted Odds Ratio (AOR) 
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Maternal characteristics associated with unscheduled visits were no maternal education 
OR=3.02, 95% CI [1.36, 6.67] and primary level of education OR=3.1, 95% CI [1.63, 5.93] 
versus tertiary level of education ; mothers engaged in farming OR=1.89, 95% CI [1.08, 3.18] 
versus laborers ; mothers living in mud type of housing OR=1.50, 95% CI [1.18, 1.91] and 
mothers living in semi-permanent OR=1.38, 95% CI [1.02, 1.85] versus mothers living in 
permanent houses ; positive HIV status OR=, 95% CI [0.43, 0.79] versus negative HIV 
status ; mothers residing in the HDSS OR=1.26, 95% CI [1.05, 1.51] versus mothers residing 
in non-HDSS area ; a unit increase in age OR=1.02, 95% CI [1.01, 1.03] were statistically 
significant by bivariate statistics. Secondary level of education, mothers working as salaried 
workers or in business or in fishing, mothers receipt of antenatal care, number of children 
mother has of her own, residency and unit increase in age were not associated bivariately 
with unscheduled visits. Multivariately, no maternal education OR=2.65, 95% CI [1.11, 6.28] 
and primary level of education OR=2.89, 95% CI [1.40, 5.94] versus tertiary level of 
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education ; positive HIV status OR=0.69, 95% CI [0.50, 0.95] versus negative HIV status ; a 
unit increase in age OR=1.02, 95% CI [1.00, 1.03] were associated with unscheduled visits. 
Secondary level of education, mothers engaged in farming or working as salaried workers or 
in business or in fishing, type of house mother is living in, mothers receipt of antenatal care, 
number of children mother has of her own and place of residency were not associated 
multivariately with unscheduled visits ((Table 11 and Figure 16). 
 
5.1. Separation of infant and maternal characteristics by unscheduled 
visits (yes) and unscheduled visits (no) 
 
An assessment of the strategy to decide whether to separate or combine infant and maternal 
characteristics by unscheduled visits (yes) and unscheduled visits (no) was carried out by 
analyzing both models and the following was established: The combined model lost a small 
amount of sample size of about 58. The combined model had one infant characteristic i.e. 
HDSS residency as statistically significant whereas four maternal characteristics that were 
statistically significant i.e., maternal education (none) and maternal education (primary), 
HDSS residency and mother’s age. In the literature review, the tendency was more focused 
towards infant characteristics to evaluate morbidity and very little of parent characteristics.  
 
In the separate model, infant characteristics: place of birth and HDSS residency were 
statistiscally significant whereas maternal characteristics: maternal education (none) and 
maternal education (primary), maternal HIV status (positive) and mother age were 
statistically significant. The difference between the two models i.e. combined is that 
combined has infant characteristic i.e. HDSS residency as statistically significant and not so 
in the separate model. In the separate model, maternal characteristic i.e. maternal HIV status 
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(positive) is statistically significant. HDSS residency is captured in both models though place 
of birth and HIV status is unique to the seprate model. 
 
5.2. Morbidity burden among infants utilizing unscheduled visits in the 
tuberculosis cohort study 
5.2.1. Inpatient versus outpatient symptoms and signs for infants 
attending unscheduled visits  
 
A total of 25,262 unscheduled visits were made to the Siaya County Referral Hospital to 
address signs and symptoms observed by the mothers. Out of the 2900 infants enrolled into 
this cohort study, 2265 (78.1%) participated in these unscheduled visits. Provision of medical 
services for the infants attending these unscheduled visits was provided for by 18 members of 
staff from the clinical team. Vomiting accounted for 4361 visits in this cohort, with 1371 
(62.3%) and 409 (44.7%) being seen as out-patients and in-patients respectively. Of these 
visits with vomit, 189 vomitted everything and out of these 63 (2.9%) and 113 (12.4%) who 
were out-patients and in-patients respectively. Infant visits associated with lethargy were 293 
and of these visits, 108 (4.9%) and 166 (18.2%) were out-patients and in-patients respectively. 
One-hundred and forty visits were associated with convulsions and 37 (1.3%) and 86 (9.4%) 
were seen as out-patients and in-patients respectively (Table 12).  
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Table 13. Signs and symptoms from infants attending unscheduled visits 
 
Inpatient symptoms 
and signs 
Inpatients 
(914; n, %) 
Inpatient 
visits 
Outpatient 
symptoms and signs 
Outpatients 
(2200; 
n, %) 
Outpatient 
visits 
Fever 846 (92.6) 6637 Breathing difficulty 2083 (94.7) 17354 
Fast breathing 457 (50.2) 717 Fever 1779 (80.9) 945 
Vomiting 409 (44.7) 470 Fast breathing 1490 (67.7) 3704 
Breathing difficulty 370 (40.5) 851 Diarrhea 1452 (66) 4607 
Nasal flaring 326 (35.7) 378 Vomiting 1371 (62.3) 3891 
Chest indrawing 311 (34) 208 Palmor pallor 389 (17.7) 522 
Diarrhea 310 (33.9) 344 Oral thrush 334 (15.2) 438 
Palmor pallor 240 (26.3) 266 Nasal flaring 284 (12.9) 315 
Lethargic 166 (18.2) 175 Diarrhea (bloody) 244 (11.1) 358 
Vomiting everything 113 (12.4) 121 Chest indrawing 181 (8.2) 365 
Convulsions 86 (9.4) 99 Pus from ear 150 (6.8) 208 
Sunken eyes 78 (8.5) 84 Measles last 3 months 126 (5.7) 141 
Oral thrush 63 (6.9) 72 Lethargic 108 (4.9) 118 
Severe wasting 62 (6.8) 74 Vomiting everything 63 (2.9) 63 
Bulging fontanelle 62 (6.8) 67 Burns 63 (2.9) 64 
Abdomen skin 55 (6) 61 Severe wasting 60 (2.7) 68 
Stridor 26 (2.8) 28 Sunken eyes 57 (2.6) 61 
Measles last 3 
months 25 (2.7) 27 Abdomen skin 50 (2.3) 53 
Oedema (both feet) 18 (2) 23 Convulsions 37 (1.3) 41 
Stiff neck 15 (1.6) 16 Swelling behind ear 23 (1) 25 
Diarrhea (bloody) 13 (1.4) 15 Bulging fontanelle 15 (0.7) 16 
Burns 10 (1.1) 11 Stiff neck 16 (0.7) 16 
Pus from ear 5 (0.5) 5 Stridor 10 (0.5) 12 
Swelling behind ear 2 (0.2) 2 Oedema (both feet) 4 (0.2) 5 
Mouth ulcers 0 (0) 0 Pus from eyes 3 (0.1) 3 
Pus from eyes 0 (0) 0 Cornea clouding 2 (0.1) 2 
Cornea clouding 0 (0) 0 Mouth ulcers 0 (0) 0 
Respiratory rate (48, 64) - - (38, 48) - 
Temperature (IQR) (36.3, 37.6) - - (37, 39.1) - 
 
Severe wasting was recorded in 142 visits and of these visits, 60 (2.7%) and 62 (6.8%) 
infants accounted for out-patient and in-patient visits respectively. Twenty-eight visits had 
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oedema that was defined as swelling of both feet and 4 (0.2%) and 18 (2%) infants showed 
up with this sign during out-patient and in-patient visits respectively. Burns in this study were 
reported in 75 visits with 63 (2.9%) and 10 (1.1%) infants being seen at out-patient and in-
patient visits respectively. Breathing difficulty was reported in 18205 visits and observed 
among 2083 (94.7%) out-patients and 370 (40.5%) in in-patients participating in unscheduled 
visits. In table 8, where normal ranges are given as 30-60 breaths/minute for less than 1 year 
old child and 24-40 breaths/minutes for 1-2 years old child, the study found that 1659 infant-
visits were above the normal respiratory rate and only 1 infant-visit was below the normal 
respiratory rate. Inter quartile range was 40-52 breaths/minutes with mean of 46.83 
breaths/minute. Fast breathing was seen in 4421 visits but recorded among 1490 (67.6%) out-
patients and 457 (50.2%) in-patients. Chest indrawing was observed in 573 visits and 
documented among 181 (8.2%) out-patients and 311 (34%) in-patients. Infants presenting 
with stridor were 10 (0.5%) and 26 (2.8%) among out-patients and in-patients respectively 
and 40 visits were associated with stridor. Nasal flaring was observed in 693 visits from 284 
(12.9%) and 326 (35.7%) out-patients and in-patients respectively. Diarrhea was reported in 
4951 visits in 1452 (66%) and 310 (33.9%) out-patients and inpatients respectively. In the 
cohort shows the duration of diarrhea and number of infants, where a majority reported 
having had diarrhea for the past 3 days, followed by 2 days. Thirty seven (37) infant visits 
had diarrhea greater than 1 week. The inter quartile range (IQR) for duration of diarrhea was 
(2-3 days). The range between the minimum and maximum duration of diarrhea was (0-90 
days). Bloody diarrhea was observed in 373 visits among 244 (11.1%) and 13 (1.4%) out-
patients and in-patients respectively. Sunken eyes was seen in 145 visits among 57 (2.6%) 
and 78 (8.5%) out-patients and in-patients respectively. Abdomen skin was observed in 114 
visits among 50 (2.3%) and 55 (6.0%) of out-patients and in-patients respectively. Fever was 
recorded in 7578 visits among 1779 (80.9%) and 846 (92.6%) out-patients and in-patients 
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respectively. The fevers were further categorized into hypothemia (36.8), normal temperature 
(36.8 ºC - 37.4ºC), low grade fever (37.5 ºC - 38 ºC) and high grade fever (>38 ºC) as shown 
in Table 12 shows that 3705/7578 (49%) had high grade fever followed by 1751/7578 (23%) 
had low grade fever. Oral thrush was observed in 510 visits among 334 (15.2%) and 63 
(6.9%) of out-patients and in-patients respectively. Palmar pallor was seen in 788 visits 
among 389 (17.7%) and 240 (26.3%) out-patients and in-patients respectively. Swelling 
behind the ear was seen in 27 visits among 23 (1%) and 2 (0.2%) out-patients and in-patients 
respectively. Pus from ear was seen in 213 visits among 150 (6.8%) and 5 (0.5%) of out-
patients and in-patients respectively. Bulging fontanelle was observed in 83 visits among 15 
(0.7%) and 62 (6.8%) of out-patients and in-patients respectively. Stiff neck was recorded in 
32 visits among 16 (0.7%) and 16 (1.6%) out-patients and in-patients respectively. Measles 
last 3 months was observed in 168 visits among 126 (5.7%) and 25 (2.7) out-patients and in-
patients respectively. No mouth ulcers were observed in this infant cohort. Pus from eyes was 
seen in 3 visits in 3 (0.1%) out-patients. Cornea clouding was observed in 2 visits in 2 (0.1%) 
out-patients.  
5.2.2. Inpatient versus outpatient clinical impressions from infants 
attending unscheduled visits  
Gastroenteritis was an impression recorded in 4768 visits among 1416 (63.4%) and 269 
(29.4%) out-patients and in-patients respectively. Upper respiratory tract infections (URTI) 
were recorded in 10643 visits among 1873 (85.1%) and 69 (7.5%) out-patients and in-
patients respectively. Malaria was suspected in 10481 visits among 1862 (84.6%) and 678 
(74.2%) of out-patients and in-patients respectively. In summary, 23985 out-patient visits 
were seen from 2200 infants who attended the unscheduled visits and the top four reasons for 
out-patient visits was as follows: breathing difficulty (2083, 94.7%), fever (1779, 80.9%), 
diarrhea (1452, 66.0%) and vomiting (1371, 62.3%).  One thousand and seventy seven visits 
resulted in hospitalization. Of these visits, 914 infants were seen during these in-patient visits, 
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the top four reasons for visits were associated with: fever (846, 92.6%), vomiting (409, 
44.7%), breathing difficulty (370, 40.5%) and diarrhea (310, 33.9%). Leading impressions 
observed by clinical team for for out-patient visits was upper respiratory tract infection 
(URTI) and for in-patient visits was malaria (Table 13). A Kilifi based study found that 
causes of all severe morbidity before 98 days included pneumonia, gastroenteritis and malaria 
(English et al., 2003) 
Table 14. Clinical impressions of infants attending unscheduled visits 
 
Inpatient clinical 
impressions 
Inpatients 
(914; n,%) 
Outpatient clinical 
impressions 
Outpatients 
(2200; n,%) 
Impression Malaria 678 (74.2) Impression URTI** 1873 (85.1) 
Impression GE* 269 (44.7) Impression Malaria 1862 (84.6) 
Impression URTI** 69 (7.5) Impression GE* 1416 (63.4) 
*GE – Gastroenteritis  ** URTI – Upper Respiratory Tract Infection 
 
5.2.3. Inpatient versus outpatient clinical investigations requested 
during unscheduled visits 
 
Haemoglobin test was ordered in 2091 visits among 889 (40.4%) and 464 (50.8%) out-
patients and in-patients respectively. Full haemogramme was investigated in 1133 visits 
among 136 (6.2%) and 750 (82.1%) out-patients and in-patients respectively. Liver function 
test (LFT) was requested in 10 visits among 4 (0.2%) and 4 (0.4%) out-patients and in-
patients respectively. Urea EC was done in 14 visits among 11 (0.5%) and 2 (0.2%) out-
patients and in-patients respectively. Blood smears for malaria parasites (BSMPS) was 
performed in 3283 visits among 1227 (55.8%) and 716 (78.3%) out-patients and in-patients 
respectively. Random blood sugar/fasting blood sugar (RBSFBS) test was requested in 399 
visits for 109 (5%) and 249 (27.2%) out-patients and in-patients respectively. Cross matching 
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for blood (GXM) was performed in 105 visits among 10 (0.5%) and 88 (9.6%) out-patients 
and in-patients respectively (Table 14). 
Table 15. Laboratory investigations requested by clinicians during unscheduled visits 
 
Inpatient 
investigations 
Inpatients  
(914; n,%) 
Outpatient 
investigations 
Outpatients 
(2200; n,%) 
BSMPS
×
 716 (78.3) BSMPS
×
 1227 (55.8) 
Hemoglobin 464 (50.8) Hemoglobin 889 (40.6) 
Full haemogramme 750 (82.1) Full haemogramme  136 (6.2) 
RBSFBS  249 (27.2) RBSFBS  109 (5) 
GXM 
Ψ
  88 (9.6) Urea EC
 α
  11 (0.5) 
Urea EC
 α
  2 (0.2) GXM
 Ψ
   10 (0.5) 
LFT  4 (0.4) LFT   4 (0.2) 
BSMPS
×
 – Blood smear for malaria parasites RBSFBS  – Random blood sugar/fasting blood sugar  
Urea EC
α
 – Urea ecotoxicity   GXMΨ – Glucuronoxylomannan 
LFT  – Liver function test 
 
5.2.4. Prescriptions dispensed to infants utilizing unscheduled visits 
A list of prescribed drugs that were dispensed during the unscheduled visits for infants who 
required treatment in the following ascending order; anti-malarials, analgesics, 
antihistamines/antiallergies, antibiotics (amoxyxillin syrup), rehydrants, vitamin supplements, 
antidiarrhoeal, antibiotics (cotrimoxazole syrup) and nasal decongestants (Table 15 and 
Figure 17).  
Table 16. Prescriptions dispensed to infants attending unscheduled visits  
Prescriptions Quantity Class Formulation 
Artemether/Lumefantrine Tablets 8970 Antimalarial Tablets 
Paracetamol Suspension 8721 Analgesic Suspension 
Chlorpheniramine suspension.  
125mg/5mls. 7364 Antihistamine/Antiallergy Suspension 
Amoxycillin syrup 5310 Antibiotic Suspension 
Oral Rehydration Salts  5217 Rehydrant Suspension 
Multivitamin Syrup 4647 Vitamin Supplement Syrup 
Zinc 4094 Antidiarrhoeal Tablets 
Cotrimoxazole Syrup 3297 Antibiotic Suspension 
Normal Saline Nasal Drops 2282 Nasal Decongestant ENT Preparation 
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5.2.5. Association of unscheduled visit days and market day 
 
We also assessed unscheduled visits by day of the week to see if there was an association 
between these visits and the market day. Monday (5990 visits) was most frequented day of 
the week followed by Tuesday (5024 visits), Friday (4910 visits), Thursday (4686 visits) and 
Wednesday (4652 visits) in that order. The market day for Siaya County is Wednesdays and 
therefore they study found no relationship between visits and market day (Figure 18).  
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5.2.6. TB suspects, TB cases and deaths with unscheduled visits 
history 
TB suspects, TB cases and deaths from unscheduled visits shows that TB suspects were 
identified through 5 approaches that included: 609/1142 (53.3%) were identified during 
unscheduled visits, 296/1142 (25.9%) identified through in-patient surveillance, 127/1142 
(11.1%) were identified at follw-up visits, 108/1142 (9.5%) were identified through out-
patient surveillance and 2/1142 (0.2%) were identified through a TB vaccine trial study. Of 
the total 48 cases of TB that were confirmed through culture and clinical evaluation, 18 cases 
were referred from the unscheduled visits. Out of the 205 deaths, 132/205 (64.4%) were 
infants who attended unscheduled visits. Proportion of male infants who died were 78/132 
(59.1%) (Table 17 and Figure 19).         
Table 17. TB suspects with unscheduled visits history 
Description of activity Proportion (n/N) Percent 
TB suspects identified during unscheduled visits 609/1142 53.3 
TB suspects identified during in-patient surveillance 296/1142 25.9 
TB suspects identified  during follow-up vists 127/1142 11.1 
TB suspects identified during out-patient surveillance 108/1142 9.5 
TB suspects identified from other study (TB vaccine trial) 2/1142 0.2 
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details of the compound where the delivery had taken place to initiate a home visit by a study 
team. Leveraging on existing structures within the HDSS platform assisted the study in 
reaching the community and enrolling this cohort. Village reporters (VRs) notified the study 
on most of the births in the study area. The VRs are trusted members the community residing 
in the same community as the mothers and infants. In a similar cohort study in neighbouring 
Uganda, village scouts were used to recruit and enroll infants into the study (Nabongo et al., 
2014). Almost all of the infants were enrolled from their homes. Many infant studies enrolled 
from health facilities. Home deliveries were higher than health facility delivery even though 
majority of mothers received antenatal care during last pregnancies. This discrepancy brings 
the need to qualitatively assess factors influencing place of delivery. Three out of 10 
deliveries occurred in the health facility but only about three out hundred infants were 
enrolled at the health facility. The study set up various field teams each comprising of nurses 
and community health workers as a strategy to succeed in home enrollments and motorbike 
transportation made penetration into community easier. Over three-quarters turned up for 
unscheduled visits thereby increasing contact between study staff and infants in need of 
clinical evaluation and treatment. The ancillary visits provided rich information for 
evaluating the free medical care visits where transport was reimbursed. Many mothers 
worked as salaried employees and lived in mud houses in this rural setting.  Mothers with 
HIV positive results in this cohort mirrored the regional data. Mothers in this cohort tended to 
have smaller families. Mothers in the cohort were younger in age. Infant accrual into the 
study took 13 months and January 2010 is singled out as the most successful month owing to 
extension of study through a protocol amendment. The infant cohort study improved BCG 
coverage by administering BCG vaccine to the community to target infants delivered in the 
homes. Reasons for study withdrawals require further qualitative investigations in the future 
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to understand why participants and mothers leave. The study demonstrated capacity to recruit 
and retain the infant cohort with an LFTU rate less than 10%.  
 
Low levels of education; mothers engaged in farming, salaried work and fishing; mothers 
living in mud type and semi-permanent houses were more likely to be associated with home 
delivery compared to health facility in this cohort. Conversely, mothers receiving antenatal 
care were less likely to deliver at home than health facility. This finding is ironical as 
majority of mothers received antenatal care from health facilities in the community. Reasons 
for preferring home delivery to health facility even after receiving antenatal care need to be 
evaluated. Education levels and antenatal care have been identified elsewhere as factors 
influencing place of delivery. Socio-economic status (SES) data was not part of information 
collected in the study though type of residence may be a proxy that indicates wealth status 
and there are studies that have found that SES affects choice of place of delivery. A study in 
Kericho, Kenya found that education and using of antenatal care services determined the 
place of delivery (Kitui et al., 2013) Overall, there is an indication that more awareness is 
necessary to increase uptake of skilled birth attendant at health facilities where only thirty 
percent of mothers in this cohort had their infants delivered. Maternal occupation such as 
those engaged in fishing, farming, salaried with tendency to deliver at home would require 
further investigation as these mothers may have been financially better placed than mothers 
working as laborers. Qualitative research on preference for home delivery is required as 
majority of the mothers in the tuberculosis cohort attended antenatal care services at facilities 
in the study area. 
 
Infants delivered at home had less LTFU due to the increased contact and rapport created by 
village reporters and study teams that visited the families in their homes upon birth 
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notifications where study information was shared, BCG vaccination administered and locator 
information taken for future reference. Increased infant weight at birth had reduced LTFU as 
these mothers may have been intrinsically motivated to participate with the view of monitor 
the wellbeing of children. Mothers who were engaged in farming and salaried work were less 
likely to be LTFU because they accessed more stable sources of income, had flexibility in 
time schedules than mothers working as laborers. Mothers living in mud housing compared to 
those living in permanent are hypothetically economically disadvantaged and therefore the 
provision of free medicare and the reimbursement of transport costs for these sick visits may 
have enhanced their participation which is the converse of a Nigerian nutrition study that 
found that low income mothers had increased LTFU (Olusegun et al., 2007). Mothers with 
more children had increased LTFU compared to mothers with fewer children probably due to 
conflict in balancing domestic and study expectations. Mothers residing within the HDSS 
area had less LTFU compared non-HDSS residents participating in the cohort study. HDSS 
has a mapping infrastructure for the homes within its community that enhance easy tracing 
and additionally, HDSS residents are better exposed to research carried out within the 
KEMRI and CDC collaboration compared to non-HDSS participants in the cohort. Older 
mothers had reduced LTFU compared to younger mothers probably because younger mothers 
tend to be more mobile and change locations thereby miss scheduled visits (Beneri et al., 
2013). Older mothers may have had increased level of awareness as they have better 
experience in raising up children that motivated them to participate for the welfare of their 
children. Prioritizing follow up efforts is critical as part of study activities to avoid attrition of 
study participants during the conduct and up to closure of the study. Retention strategies such 
as clinic staff providing good medical care to infants, transport reimbursements for scheduled 
visits, indicating the next visit date on study card, issuing reminders, physical tracing and 
open days were utilized. 
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Home delivered infants attended more unscheduled than health facility delivered infants. 
Mothers who delivered at the health facility had a better health seeking than mothers who 
delivered at home. However, we posit that the latter mothers may have taken advantage of a 
medical care system that was free and transport reimbursed for sick visits. Similarly mothers 
with lower education levels have may not necessarily sought medical care for any other 
reason than the instrinsic benefits (Ndugwa and Zulu, 2008). On the other hand, mothers 
residing in the HDSS had less unscheduled visit attendances compared to those residing 
outside the HDSS may be due to previous experience with research activities from KEMRI 
and CDC collaboration and therefore better able to differentiate between research and 
medical services. HIV positive mothers had fewer unscheduled visits compared to HIV 
negative probably due to better health seeking behavior and therefore better positioned to 
discriminate the need for an unscheduled visits or not.  
 
The leading symptoms for inpatient visits were fevers (Nnedu et al., 2010), fast breathing and 
vomiting whereas for outpatient unscheduled visits were breathing difficulty (Chintu et al., 
2002), fevers and fast breathing. Inpatient visits had higher temperatures and respiratory rates 
compared to outpatient visits. Leading clinical impressions were malaria and upper 
respiratory tract infection for inpatient and outpatient visits respectively. For all unscheduled 
visits, the commonly requested laboratory investigations were blood smears for malaria, 
hemoglobin and full haemogramme. Antimalarials, analgesics and antihistamines were the 
most prescribed medication during these sick visits. We evaluated the relationship between 
unscheduled visits and market day in the community which was Wednesday and found no 
correlation as most visits were made on Mondays, Tuesdays and Fridays. TB suspects were 
identified during the unscheduled visits and referred for further investigation at the case 
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verification (CV) ward in Siaya County Referral Hospital. TB cases were identified that 
would have otherwise been missed without provision and facilitating of free medical care 
visits. 
Table 19. Thesis objectives by relevant variables, target variables and references 
Objective Relevant variables Target variable Reference 
Recruitment 
outcomes - 
notifications 
Village reporters, 
health facility staff or 
other strategies 
deployed to refer 
potential participants 
to the study 
Village reporters 
similar to scouts used 
in Uganda neonatal 
study for referring 
infants 
Nabongo et. al., 2014 
Factors associated 
with place of 
delivery 
Maternal education 
(none, primary and 
secondary) 
Mother occupation 
(farming, salaried 
worker and fishing) 
Housing type (mud, 
semi-permanent) 
Receipt of antenatal 
care (yes) 
Lower levels of 
education and access 
to antenatal care 
services associated 
with hospital delivery 
Kitu et. al., 2013 
Factors associated 
with loss to follow up 
(LTFU) 
Place of birth (home) 
Infant birth weight 
Maternal occupation 
(farming, salaried 
worker) 
Housing type (mud) 
Number of children 
mother has of her 
own (≤ γ) 
Low income mothers 
had increased LTFU 
 
Younger mothers had 
increased LTFU 
Olusegun et. al., 
2007 
 
Beneri et. al., 2013 
Factors associated 
with attendance of 
unscheduled visits 
Residency (HDSS) 
Mother education 
(none and primary) 
HIV status (positive) 
Mother Age 
Mothers with lower 
educational levels 
sought medical care 
for their sick babies 
Ndugwa and Zulu, 
2008 
Morbidity burden – 
symptoms associated 
with unscheduled 
visits 
Leading signs and 
symptoms during 
inpatient visits were 
fever, fast breathing 
and vomiting 
compared to 
breathing difficulty, 
fever and fast 
breathing for 
outpatient visits. 
Fevers were 
associated with sick 
visits 
 
Breathing difficulty 
was associated with 
medical care visits 
Nnedu et. al., 2010 
 
 
 
Chintu et. al., 2002 
 
108 
 
7. Conclusion 
 
We demonstrated the capacity to recruit, enroll and retain the infant cohort. Utilization of 
VRs was pivotal in successful accrual of infants into the tuberculosis cohort study. The study 
managed to improve BCG vaccination in the county tremendously. Further qualitative 
research is needed to understand reasons for withdrawal and choice of place of delivery. 
Consideration of protectors and predictors of LTFU in planning and implementation of future 
pediatric studies is recommended. However, these need to be validated as findings are not 
generalizable. Additionally, assessment of recruitment and retention strategies is important in 
measuring efforts and monies put in versus outcomes. The utility of unscheduled visits is 
better understood to inform planning and management of free medical care in the study. 
There are benefits associated with unscheduled visits in terms of maintaining contact with 
research participants thereby increasing retention and identification of study endpoints that 
may be missed in routine study visits. There are costs involved in provision of free medical 
services that sites need to negotiate with sponsors as financial agreements are signed.  This 
study has availed information that is useful for those planning to recruit infants in large phase 
III trials in developing countries to avoid pitfalls that come with high loss to follow up which 
affect measurement of trial endpoints. 
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Informed Consent Form 
 
Protocol Title: A Prospective Epidemiological Cohort Study to Evaluate the Incidence of TB in 
Infants in Western Kenya 
 
Introduction 
We are requesting you to allow your child to take part in medical research. Research is also called a 
study. A medical study can look at what causes a disease. It can also look at ways to prevent or 
control a disease.  
 
The following information will tell you about the study and your child’s part in it. Please listen 
carefully. Feel free to ask any questions. This is a research study being done by KEMRI/CDC.  
 
Voluntary Participation 
You may decide not to have your child be in this study. No health care benefit will be taken away 
from you or your child if you decide to say no. Your child can leave the study at any time. There will 
be no penalty or loss of benefits if you do not participate. 
 
Background 
Experts believe that BCG vaccination helps prevent severe tuberculosis (TB) in children. BCG is one 
of the most widely used vaccines in the world. It has been given to almost all newborns in Kenya for 
many years. Still, TB is a common cause of infant, child and adult deaths in Kenya. TB is caused by a 
germ that is inhaled into the lungs. Most people do not get disease but the germ lives in them for 
many years. This is called TB infection. Some people may feel ill and have symptoms very quickly; 
others develop signs and symptoms much later. This is called TB disease. Finding germs in the 
sputum confirms TB disease. New vaccines for TB are being created. These will most likely be given 
to infants.  
 
Reason for the Study 
The researchers conducting this studywant to find out the amount of TB infection and TB disease in 
infants in this community. They also want to find out if a TB vaccine study could be done in infants in 
this community and whether it is possible to vaccinate all newborns with the regular BCG within 4 
days. They would also like to find out the clinical predictors for TB in a place where HIV is also 
common. HIV is the virus that causes the Acquired Immune Deficiency Syndrome (AIDS). HIV 
infection occurs in some infants because the virus is carried from the mother to the baby during the 
pregnancy or during delivery or during breast-feeding. If an infant is infected with HIV, the mother is 
almost always also infected. HIV is commonly spread by sexual intercourse in adults.  
 
Since HIV infection will affect the immune system, it is important to know if an infant is infected 
with HIV before trying to understand your child’s response to TB. You will be informed of the results 
120 
 
of your child’s HIV test. No one else (for example, your sexual partner) will be informed of your 
child’s status, unless you give the counselors your permission to inform them. If the results are 
positive you, your child, and others in your family will be referred to the best management that our 
health care system provides, including pre- and post-test counseling and HIV tests for family 
members who desire it. The counselors who will see you are very aware that being known to be HIV 
positive can lead to people being unfairly shunned or otherwise victimized by members of their 
community, and will support you and advise you on how best to cope with this possibility.  
 
Procedures to be followed 
This study does not use an experimental drug or vaccine. The study is being done in Karemo division 
and contiguous areas e.g Boro, Gem etc. Study staff are aiming to enroll all infants born in this area. 
Permission to enroll the infants will be obtained from the infants’ mother, as soon as possible after 
delivery, either at the mothers’ homes (if the infant was born at home) or at a health facility (if the 
infant was born at a health facility). To enroll in the study, an infant must receive the regular BCG 
used in the public clinics but given by study staff, and must be available for follow up for at least one 
year after birth. When we enroll your infant into this study, we would also like to know the mother’s 
HIV status. This information will enable us to take steps that will prevent mother to child transmission 
of HIV. It will also enable us to link both the mother and the infant to HIV treatment and care services 
near them. If we enter you into the study while pregnant, we will seek permission to access your HIV 
test result if already tested, if you are not tested, we will encourage you to get tested at the nearest 
HIV testing center. If the result is positive and you are enrolled for HIV care, you will be given a drug 
during labor to prevent the transmission of the HIV virus to your child. Your child will also be given a 
drug within 3 days of delivery and another one to take everyday for one month. You will also be 
advised on safe infant feeding practices to prevent your child from getting infected with the HIV virus. 
We will also ask you to come back for another HIV test when your baby is six weeks old. This test 
will inform us if the baby has the HIV infection or not. If we enter you into the study after the birth of 
the baby, and you have not had an HIV test in the preceding 2 months, or were tested more than 2 
months ago and had a negative result, we you will request you to be tested again. If you were or are 
tested and the result was/ is positive, you will be given a drug known as Nevirapine to take at the 
onset of labor and your baby child will also be given some drugs: Nevirapine for three days and 
zidovudine for 1 month. These drugs prevent transmission of the virus from mother to the child. In 
addition, your baby will be given daily septrin and multivitamins. until we do another HIV test when 
the baby is six weeks old. This test at the age of six weeks will be done on all babies. This particular 
test will inform us whether your infant is infected with the HIV virus or not. We would like to test 
your child for the HIV virus when they are admitted to hospital. The HIV testing in this  study is 
entirely voluntary. You may choose to participate in this study without undergoing HIV testing. 
Follow up 
Your infant will be followed up once every four months for up to 2 but at least one year. This means 
that a study staff member will arrange to meet you at the health facility you routinely attend, 
every fourth month to examine and weigh your infant and to ask you questions about your infant’s 
health, including questions about signs and symptoms of TB in your infant and possible exposure to 
TB. we will give you Ksh 150 as reimbursement for your transport costs.If you don’t make it to 
the health facility, a study nurse will visit you at your home, and  therefore for this, there shall 
be no reimbursement. Study staff may also look at your infant’s clinic and/or hospital records to see 
if s/he has been examined for TB or diseases that might be TB. If TB is suspected in your infant, you 
will be asked to bring him/her to the Siaya District Hospital for special tests. These are described in a 
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later section of this document on TB diagnosis. The study staff will also offer HIV testing and 
counseling if your baby  was / you were negative or was / were not tested at the beginning of the study. 
 
TB Diagnosis  
If study staff suspect your infant may have TB or that s/he has been exposed to TB, they will ask you 
to bring your infant to the Case Verification Ward at Siaya District Hospital. Transportation to the 
ward will be provided by the study. You and your infant will be admitted in the afternoon and you 
will spend two nights together in the ward. Each morning a study nurse will use a small tube to 
remove some contents from your infant’s stomach.  A spray to make your infant cough and then a soft 
suction catheter will be used to remove the material coughed up from your infant’s throat. This 
material will be tested for the germ that causes TB. These procedures are normal tests used to 
diagnose TB in infants but are not normally available in our public health facilities. Your infant will 
also receive a skin test that shows if your child has come into contact with the germ that causes TB, 
and will also have a chest X-rays done  
 
If your infant is admitted to the case verification ward for TB tests, you will be given and asked to 
sign another consent form with more detail about the tests, including the risks and benefits of these 
tests. 
Mother’s Finger Print and Baby’s Toe print 
As part of your participation in this study, we wish to scan your finger print and your baby’s toe print.  
The fingerprint reader will not store the image of your finger print or your baby’s toe- print, but will 
use the skin lines and ridges to create a number that is unique to each person.  No one can re-create a 
copy of your finger print or baby’s toe print from this number. It is of no use to anyone, including the 
police. At every clinic visit, your finger print or baby’s toe print will be scanned. This will confirm 
that it is you who has come for that particular visit. This will enable us to better identify you so that 
we can link your residency information with your health records with ease. All the pieces of 
information about you and your family, including the fingerprint code will be kept in strict confidence 
and will not be subjected to any other use other than for identification purposes during study visits. 
 
Risks finger print or toe print scanning:   
We do not believe there are any serious risks involved in having your finger- or toe- print scanned.   
 
You are free to choose for you and your baby to have your finger- or toe- prints scanned respectively.  
You have the right to refuse.   You can still participate in this study even if you refuse to have your 
finger print or baby’s toe print scanned.   
 
Study Close Out 
At the end of follow-up (at least 1 year, maximum 2 years) you) we will ask you about TB signs and 
symptoms concerning your infant and yourself. Study staff  will also ask you about people suffering 
from TB who might live in your home. If your infant has signs or symptoms of TB, s/he will be 
referred to the case verification ward at Siaya District Hospital as mentioned previously for further TB 
investigations.  
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Linkage with DSS Data 
Your family may be part of the KEMRI/CDC Demographic Surveillance System (DSS). That is a 
different study from this study. The DSS collects information on: 
1. The number of births and deaths in the ccommunity 
2. How much education people have 
3. How wealthy or poor people are 
4. How much community members use health services and why 
5. Other factors which are important in controlling infectious diseases and promoting health in 
the community.  
If  you allow  your child to  take part in this study and your family is also part of the KEMRI/CDC 
DSS, we  will link some information from the DSS to this study. This would link some information 
about your household with your child’s information from this TB study, such as: 
1. the number of people living in your house  
2. The characteristics of your household, and so on. 
3. Any visits made to the health facilities within and outside Karemo and contiguous areas e.g 
Boro, Gem etc. 
Should your child die, the DSS may collect information about your child’s death which they will 
share with us.but we shall not be giving any information to the DSS about you or your involvement 
in the study. 
If your family is not part of the KEMRI/CDC DSS, it will be impossible to link to information about 
your family’s household unless you provide this information to the study staff. 
Cause of Death Investigations: 
To prepare for a vaccine study it is important to know the cause of death if someone passes away. If 
your child was to pass away, we would want to know if TB or a related condition has something to do 
with the death. This will require further investigations. We will approach you to discuss these with 
you in more detail should your child pass away. 
 
Exclusions 
Your child will not be eligible for the study if you do not plan to stay in the study area for at least one 
year after the birth of your infant. There may be other reasons why your infant cannot participate. The 
study staff will discuss these with you.  
 
Risks and Benefits to Your Child  
Since your infant will be under active surveillance for TB, s/he will benefit by receiving an earlier 
diagnosis of TB and have less severe disease. The TB tests used in the study are usually not available 
in the public health facilities. 
You and your child will also receive early referral for HIV treatment and care if found to be HIV 
positive. If you are infected with HIV, we will also advise you on way to prevent your baby from 
getting infected 
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 There may be a small risk to your child from the tests used to diagnose TB. These will be explained if 
you are asked to bring your child in for testing.  
 
Refund 
If you have to pay for transportation to the Siaya District Hospital when you come to our clinic or 
when your child is admitted to the case verification ward, you will be given back the amount of Kshs 
100-400, depending on the distance travelled. If you and your child are admitted to the CVW in SDH, 
you will be given some baby products whose value shall not be more than Kshs 500.at the time of 
discharge. 
If your child suffers any adverse vaccine effects as a direct result of the BCG vaccine, the government 
health services will provide medical care.  
 
Privacy 
You will receive a copy of this consent form. The researchers conducting this study will keep your 
child’s study records strictly private. Nobody else but they and their staff will see your records unless 
you give them permission. Your child’s name will not appear in any publication written from this 
study.  
 
Contact Information for Questions or Concerns 
The study has been approved by: 
1. The National Ethical Review Committee (ERC), Kenya Medical Research Institute (KEMRI) 
2. The Institutional Review Board of the Centres for Disease Control and Prevention (CDC) in 
the United States of America. 
3. The Institutional Review Board used by the Aeras Global TB Vaccine Foundation.   
 
If you have questions about your child’s rights being in research, you should contact: 
The Secretary of KEMRI NERC on (020) 2722541 or 0722205901, fax (254) (020) 2720030, 
P.O.Box 54840-00200 Nairobi-Kenya. 
If at any time, you have questions or concerns about this study or your child is injured as a result of 
being in this study you should contact:  
Dr Videlis Nduba or Dr. Anja Van’t Hoog at KEMRI/CDC Field Research station at Kisian, Kisumu. 
(P.O. Box 1578, Kisumu) at telephone 057-20-22902/59/83.  
By signing Box A below, I agree that: 
 I have read this consent form or had it read to me. 
 I have had the chance to ask questions and they have been answered. 
 I understand that my child taking part in this study is my free choice 
 I give permission to use and share my child’s health and research data as described in this form. 
 I have the ability to withdraw my child at any time with no penalties or consequences 
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Case Report Form Content for Enrollment 
 
Study Day 0: (Birth) - Visit 1 
Verify eligibility criteria 
Written informed consent from parent / guardian 
 Entry and assignment of SIN 
History from parent/guardian, including: 
 Demographic characteristics of parent(s) and infant 
 Details of infant’s BCG immunization if already given at hospital or administer BCG 
for infants delivered at home and exact date after birth. 
 History of close contact with a person with confirmed TB 
 Maternal HIV/PMTCT status Plus referral if not HIV tested or tested  2 months ago 
 Infant’s medical history  
 Birth history (e.g. birth weight, complications) 
 History of hospitalizations since birth 
 Diagnoses made of acute or chronic diseases since birth 
 Current signs or symptoms of TB 
Physical examination of the infant, including  
 Weight / head circumference/ height 
 Congenital anomalies of the face and/or central nervous system. 
 Evaluation of BCG injection site (BCG scar) and axillary lymph nodes of injection 
arm 
 Parent/guardian given information on BCG side effects 
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Case Report Form Content for Follow Up Visit (1) 
 
Study Day 42 [±7]: (6 weeks) - Visit 2 
HIV counseling and testing (PCR) of infant 
History from parent/guardian, including: 
 History of close contact with an adult with confirmed TB during last 4 months 
 Infant’s medical history, including assessment of adverse events 
 History of hospitalizations during last 4 months  
 Diagnoses made of acute or chronic diseases during last 4 months 
 Current signs or symptoms of TB 
Physical examination of the infant, including  
 Weight 
 Evaluation of BCG injection site and all nodes.  
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Case Report Form Content for Follow Up Visit (2) 
 
Study Day 119 [±14]: (4 months) - Visit 3 
Study Day 245 [±14]: (8 months) - Visit 4 
Study Day 483 [±14]: (16 months) - Visit 6 
Study Day 609 [±14]: (20 months) - Visit 7 
Study Day 728 [±14]: (24 months) - Visit 8 
History from parent/guardian, including: 
 History of close contact with an adult with confirmed TB during last 4 months 
 Infant’s medical history, including assessment of Adverse Events 
 History of hospitalizations during last 4 months  
 Diagnoses made of acute or chronic diseases during last 4 months 
 Current signs or symptoms of TB 
  
Physical examination of the infant, including  
 Weight 
Evaluation of BCG injection site and all nodes 
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Case Report Form Content for Follow Up Visit (3) 
Study Day 364 [±14]: (1 year) - Visit 4 
History from parent/guardian, including: 
 History of close contact with an adult with confirmed TB during last 4 months 
 Infant’s medical history, including assessment of Adverse Events 
 History of hospitalizations during last 4 months  
 Diagnoses made of acute or chronic diseases during last 4 months 
 Current signs or symptoms of TB 
Physical examination of the infant, including  
 Weight, (height needed for percentile charting) 
 BCG scar 
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Table 20. Variables description, codes, values and names 
Description Codes/values Name 
Mother's occupation 1=Farming momoccupation 
2=Salaried worker 
3=Business 
4=Labor 
5=Fishing 
Mother HIV status 1=Negative rechivresultsas 
2=Positive 
Lost to follow-up status 1=Lost retained 
2=Retained 
Type of Housing 1=Mud housingtype 
2=Semi-permanent 
3=Permanent 
4=Other 
Mother received antenatal care 1=Yes recreceivedantentlcare 
2=No 
3=Unknown 
Number of children mother own 1=<3 children mothersown 
2=>=3 children 
Mother's level of education 1=None momeducationlevelf 
2=Primary 
3=Secondary 
4=Tertiary 
5=Unknown 
Residency 1=HDSS demdssidstatus 
2=Non-HDSS 
Infant's sex 1=male enrsex 
2=female 
Place of birth 1=home enrplaceofbirthf 
2=Health facility 
Mother's age  Years mumage 
Infant's age years age 
Number of infants delivered 1=Singleton enrinfantsdelivered 
2=Twins 
Birth weight Kg   
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Statistical Analyses 
 
Univariate analysis 
Descriptive statistics were used to describe the efforts and outcomes of recruitment, 
enrollment, follow up and retention using a flow chart where counts and percentages are 
presented. Recruitment strategies and BCG profiles were described using table of frequencies, 
percentages and pie charts. A line graph was used to illustrate the accrual of infants into the 
tuberculosis cohort by month and year. A histogram was used to describe the age distribution 
of the infant cohort. Infant and maternal characteristics collected at enrollment were 
summarized in pie charts using percentages. Table of count and frequencies were used to 
summarize infant and maternal characateristics.  Infants and maternal characteristics are 
summarized in table of percentiles. 
Bivariate analysis and logistic regression 
Maternal factors for place of delivery were tabulated in crude odds ratio and p-values for 
bivariate characteristics considering whereas for logistic regression was presented in adjusted 
odds ratio to control for confounding using p=0.05 as the rest for statistical significance. 
Graphical illustration was used to depict the multivariate analyses pictorially. 
Infant and maternal factors associated with LTFU versus retained and unscheduled visits (yes 
versus no) were tabulated in crude odds ratio and p-values for bivariate characteristics 
considering Chi-square test for 2 X 2 tables and Mantel Haenszel test for greater that 2 X 2 
tables whereas for logistic regression was presented in adjusted odds ratio to control for 
confounding using p=0.05. Graphical illustrations for infant and maternal characteristics were 
used to depict the multivariate analyses for infant and maternal factors associated with LTFU 
versus retained and unscheduled visits (yes versus no) pictorially. 
Kaplan Meier Estimation was used to explore predictors of LTFU through exploratory 
analysis using graphical curves with p=0.05 as the test for statistical significance. 
Cox Proportional Hazards model was used to assess for factors associated with LTFU only 
for both infant and maternal characteristics. Log rank test was used to assess binary variables 
where Generalized Wilcoxon test was used for variables > 2. 
Signs and symptoms among infants attending unscheduled visits were tabulated in order of 
higher frequency and percentage divided into inpatient and out patient categories. Leading 
clinical impressions were tabulated and split between inpatient and outpatient visits. 
Laboratory investigations requested by clinicians during inpatient and outpatient unscheduled 
visits were tabulated accordingly. Prescriptions dispensed during unscheduled visits were 
tabulated by medication, class, count and formulation. A pie chart was used to pictorially 
represent the prescriptions. An association between unscheduled visit days and market day 
was illustrated graphically. TB suspects with unscheduled visits history were tabulated to 
depict the source of identification followed by pie chart.  TB cases and deaths with 
unscheduled visits history were tabulated.  
   
